<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antihypertensives Learning Module (ADHD Friendly)</title>
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;700&family=Open+Sans:wght@400;600&display=swap');

        :root {
            --primary-color: #007bff; /* Blue */
            --secondary-color: #28a745; /* Green */
            --accent-color: #ffc107; /* Yellow */
            --alert-color: #dc3545; /* Red */
            --info-color: #17a2b8; /* Cyan */
            --text-color: #333;
            --bg-light: #f8f9fa;
            --bg-white: #ffffff;
            --border-color: #dee2e6;
            --shadow-light: rgba(0, 0, 0, 0.1);
            --focus-border: #6c757d; /* Gray for focus boxes */
            --quiz-bg: #d4edda; /* Light green for quizzes */
            --reveal-bg: #e9ecef; /* Light gray for revealed content */
            --drug-card-bg: #f0f0f0; /* Light gray for drug quiz card */
            --button-mastered: #28a745; /* Green for Yes */
            --button-missed: #dc3545; /* Red for No */
            --progress-bar-bg: #e0e0e0;
            --progress-bar-fill: #4CAF50; /* Green fill */
            --break-prompt-bg: #ffebee; /* Light red for break prompts */
            --break-prompt-border: #ef9a9a; /* Medium red for border */
        }

        /* Crucial adjustments for iframe scrolling */
        html, body {
            height: 100%; /* Make sure HTML and Body fill the iframe */
            margin: 0;
            padding: 0;
            overflow-x: hidden; /* Prevent horizontal scrollbar */
            overflow-y: auto; /* Allow vertical scrolling within the iframe */
        }

        body {
            font-family: 'Open Sans', sans-serif;
            line-height: 1.6;
            color: var(--text-color);
            background-color: var(--bg-light);
            transition: font-size 0.2s ease, filter 0.5s ease-in-out; /* Smooth text size change and blur */
        }

        /* Styles for blurring the background content */
        body.blurred > *:not(#clockOutOverlay) {
            filter: blur(5px);
            pointer-events: none; /* Disables interaction with blurred content */
            user-select: none; /* Prevents text selection on blurred content */
        }

        .container {
            width: 100%; /* Changed from max-width to width to make it span full screen */
            margin: 20px auto; /* Keep vertical margin, auto for horizontal centering when not 100% wide */
            padding: 20px min(5vw, 60px); /* Responsive horizontal padding, min 20px, max 60px or 5vw */
            background-color: var(--bg-white);
            border-radius: 8px;
            box-shadow: 0 4px 15px var(--shadow-light);
            box-sizing: border-box; /* Include padding and border in the element's total width and height */
            min-height: calc(100vh - 40px); /* Ensure container is tall enough to trigger scroll */
        }

        header {
            background-color: var(--primary-color);
            color: white;
            padding: 25px 20px;
            border-radius: 8px 8px 0 0;
            text-align: center;
            margin-bottom: 20px;
            position: relative; /* For progress bar positioning */
        }

        header h1 {
            margin: 0;
            font-family: 'Roboto', sans-serif;
            font-weight: 700;
            font-size: 2.5em;
        }

        /* Module Progress Bar */
        #moduleProgressBarContainer {
            width: 90%;
            height: 10px;
            background-color: var(--progress-bar-bg);
            border-radius: 5px;
            margin: 15px auto 0;
            overflow: hidden;
        }

        #moduleProgressBar {
            height: 100%;
            width: 0%;
            background-color: var(--progress-bar-fill);
            border-radius: 5px;
            transition: width 0.5s ease-in-out;
        }

        nav {
            background-color: var(--secondary-color);
            padding: 10px 0;
            border-radius: 0 0 8px 8px;
            margin-bottom: 20px;
            box-shadow: 0 2px 5px var(--shadow-light);
        }

        nav ul {
            list-style: none;
            padding: 0;
            margin: 0;
            display: flex;
            justify-content: center;
            flex-wrap: wrap;
        }

        nav ul li {
            margin: 5px 15px;
        }

        nav ul li a {
            color: white;
            text-decoration: none;
            font-weight: 600;
            padding: 8px 12px;
            border-radius: 5px;
            transition: background-color 0.3s ease;
            cursor: pointer; /* Keep pointer cursor as they are clickable via JS */
        }

        nav ul li a:hover, nav ul li a.active {
            background-color: rgba(255, 255, 255, 0.2);
        }

        nav ul li a.completed {
            background-color: #1e7e34; /* Darker green for completed */
            box-shadow: inset 0 0 5px rgba(0,0,0,0.3);
        }


        h2, h3, h4 {
            font-family: 'Roboto', sans-serif;
            color: var(--primary-color);
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 5px;
            margin-top: 30px;
        }

        h2 {
            font-size: 2em;
        }

        h3 {
            font-size: 1.5em;
        }

        h4 {
            font-size: 1.2em;
            border-bottom: 1px dashed var(--border-color);
            margin-bottom: 15px;
        }

        section {
            margin-bottom: 25px;
            padding: 15px;
            background-color: var(--bg-white);
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            transition: transform 0.2s ease-in-out;
        }

        section:hover {
            transform: translateY(-3px);
        }

        .objectives ul {
            list-style-type: disc;
            padding-left: 20px;
        }

        .objective-item {
            margin-bottom: 8px;
        }

        .info-card {
            background-color: var(--bg-light);
            border-left: 5px solid var(--info-color);
            padding: 15px;
            margin: 20px 0;
            border-radius: 5px;
        }

        .reveal-button {
            background-color: var(--accent-color);
            color: var(--text-color);
            border: none;
            padding: 10px 15px;
            border-radius: 5px;
            cursor: pointer;
            font-size: 1em;
            margin-top: 10px;
            transition: background-color 0.3s ease;
            display: block; /* Make button full width */
            width: fit-content; /* Adjust width to content */
        }

        .reveal-button:hover {
            background-color: #ffda6a;
        }

        .reveal-content {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background-color: var(--reveal-bg);
            border-left: 3px solid var(--secondary-color);
            border-radius: 5px;
        }

        .question-card {
            background-color: var(--quiz-bg);
            border: 1px solid #c3e6cb;
            padding: 20px;
            margin: 30px 0;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.1);
        }

        .question-card p {
            font-weight: 600;
            color: #155724;
            margin-bottom: 15px;
        }

        .question-card .options label {
            display: block;
            margin-bottom: 10px;
            cursor: pointer;
        }

        .question-card .options input[type="radio"],
        .question-card .options input[type="checkbox"] {
            margin-right: 8px;
        }

        .question-card .feedback {
            margin-top: 15px;
            padding: 10px;
            border-radius: 5px;
            display: none;
        }

        .question-card .feedback.correct {
            background-color: #d1ecf1; /* light blue */
            color: #0c5460; /* dark blue */
            border: 1px solid #bee5eb;
        }

        .question-card .feedback.incorrect {
            background-color: #f8d7da; /* light red */
            color: #721c24; /* dark red */
            border: 1px solid #f5c6cb;
        }

        .question-card .submit-btn {
            background-color: var(--primary-color);
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 5px;
            cursor: pointer;
            margin-top: 15px;
            transition: background-color 0.3s ease;
        }

        .question-card .submit-btn:hover {
            background-color: #0056b3;
        }


        .prototype-drug-chart {
            border: 1px solid var(--border-color);
            border-collapse: collapse;
            width: 100%;
            margin: 20px 0;
            font-size: 0.9em;
        }

        .prototype-drug-chart th, .prototype-drug-chart td {
            border: 1px solid var(--border-color);
            padding: 8px;
            text-align: left;
        }

        .prototype-drug-chart th {
            background-color: var(--primary-color);
            color: white;
            font-weight: bold;
        }

        .prototype-drug-chart tr:nth-child(even) {
            background-color: #f2f2f2;
        }

        .note, .focus-prompt, .quick-fact, .patient-safety {
            padding: 15px;
            margin: 20px 0;
            border-radius: 5px;
            font-weight: 600;
        }

        .note {
            background-color: #fff3cd;
            border-left: 5px solid #ffc107;
            color: #856404;
        }

        .focus-prompt {
            background-color: #d1ecf1; /* light blue */
            border-left: 5px solid #0c5460; /* dark blue */
            color: #0c5460;
        }

        .quick-fact {
            background-color: #e2f0d9; /* very light green */
            border-left: 5px solid #6ab04c; /* medium green */
            color: #4a7d32;
        }

        .patient-safety {
            background-color: #f8d7da; /* light red */
            border-left: 5px solid #dc3545; /* Red */
            color: #721c24; /* dark red */
        }

        .highlight {
            background-color: #ffe082; /* Light yellow for highlighting key terms */
            padding: 2px 4px;
            border-radius: 3px;
        }

        .nclex-next-gen {
            background-color: #e6f7ff;
            border: 2px solid #a6d9f5;
            padding: 25px;
            margin: 40px 0;
            border-radius: 10px;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.08);
        }

        .nclex-next-gen h3 {
            color: #2196f3;
            border-bottom: 1px dashed #a6d9f5;
            padding-bottom: 10px;
            margin-top: 0;
            margin-bottom: 20px;
        }

        .nclex-next-gen .case-study {
            margin-bottom: 20px;
            font-style: italic;
        }

        .nclex-next-gen .fill-in-the-blank {
            margin-top: 20px;
        }

        .nclex-next-gen .fill-in-the-blank input[type="text"] {
            padding: 8px;
            border: 1px solid var(--border-color);
            border-radius: 4px;
            width: calc(100% - 20px);
            margin-top: 10px;
        }

        .nclex-next-gen .fill-in-the-blank button {
            margin-top: 15px;
        }

        .nclex-next-gen .rationale {
            background-color: #e0f2f7;
            border-left: 4px solid #4a90e2;
            padding: 15px;
            margin-top: 20px;
            border-radius: 5px;
            display: none;
        }

        .nclex-next-gen .rationale p {
            margin: 0;
            font-size: 0.95em;
        }

        .nclex-next-gen table.responsive-table th,
        .nclex-next-gen table.responsive-table td {
            text-align: left !important; /* Override center alignment for clarity in rationale */
        }
        .nclex-next-gen table.responsive-table td input[type="checkbox"],
        .nclex-next-gen table.responsive-table td input[type="radio"] {
            margin-left: 0; /* Align checkbox */
        }
        .nclex-next-gen .blank-underline {
            border-bottom: 1px solid #333;
            padding-bottom: 2px;
            margin: 0 5px;
            display: inline-block;
            min-width: 50px;
        }


        .figure-placeholder {
            text-align: center;
            margin: 20px 0;
            padding: 15px;
            background-color: #eef;
            border: 1px dashed #bbb;
            border-radius: 5px;
            color: #666;
            font-style: italic;
        }

        .recap {
            background-color: #f0f8ff; /* Lighter blue */
            border-left: 5px solid #add8e6; /* Light steel blue */
            padding: 15px;
            margin: 25px 0;
            border-radius: 5px;
            font-weight: 500;
        }
        .recap h4 {
            color: #36a2eb;
            border-bottom: 1px solid #add8e6;
        }


        footer {
            text-align: center;
            padding: 20px;
            margin-top: 30px;
            background-color: var(--primary-color);
            color: white;
            border-radius: 0 0 8px 8px;
        }

        /* Tooltip styles */
        .tooltip-container {
            position: relative;
            display: inline-block;
            cursor: help;
            border-bottom: 1px dotted var(--primary-color); /* Underline for tooltips */
        }

        .tooltip-text {
            visibility: hidden;
            width: 250px;
            background-color: #555;
            color: #fff;
            text-align: center;
            border-radius: 6px;
            padding: 5px 10px;
            position: absolute;
            z-index: 1;
            bottom: 125%; /* Position above the text */
            left: 50%;
            margin-left: -125px; /* Center the tooltip */
            opacity: 0;
            transition: opacity 0.3s;
            font-size: 0.85em;
        }

        .tooltip-text::after {
            content: "";
            position: absolute;
            top: 100%; /* At the bottom of the tooltip */
            left: 50%;
            margin-left: -5px;
            border-width: 5px;
            border-style: solid;
            border-color: #555 transparent transparent transparent;
        }

        .tooltip-container:hover .tooltip-text {
            visibility: visible;
            opacity: 1;
        }

        /* Drug Mastery Quiz Specific Styles */
        #drug-mastery-quiz .quiz-card {
            background-color: var(--drug-card-bg);
            border: 1px solid var(--primary-color);
            padding: 25px;
            margin: 30px auto;
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.15);
            max-width: 600px;
            display: none; /* Hidden until quiz starts */
            text-align: center;
        }

        #drug-mastery-quiz .quiz-card h4 {
            color: var(--primary-color);
            margin-bottom: 10px;
            font-size: 1.8em;
            border-bottom: none; /* Override default h4 border */
        }

        #drug-mastery-quiz .quiz-card p {
            font-size: 1.2em;
            margin-bottom: 20px;
            font-weight: normal;
        }

        #drug-mastery-quiz .quiz-controls {
            margin-top: 20px;
            display: flex;
            justify-content: space-around;
            gap: 10px;
        }

        #drug-mastery-quiz .quiz-controls button {
            flex: 1;
            padding: 12px 20px;
            border: none;
            border-radius: 8px;
            font-size: 1.1em;
            cursor: pointer;
            transition: background-color 0.3s ease, transform 0.1s ease;
        }

        #drug-mastery-quiz .quiz-controls button:active {
            transform: translateY(1px);
        }

        #drug-mastery-quiz #startQuizBtn {
            background-color: var(--secondary-color);
            color: white;
            display: block;
            margin: 20px auto;
            width: fit-content;
            padding: 15px 30px;
            font-size: 1.4em;
        }
        #drug-mastery-quiz #startQuizBtn:hover {
            background-color: #218838;
        }

        #drug-mastery-quiz #showAnswerBtn {
            background-color: var(--accent-color);
            color: var(--text-color);
        }
        #drug-mastery-quiz #showAnswerBtn:hover {
            background-color: #e0a800;
        }

        #drug-mastery-quiz #answerFeedback {
            margin-top: 20px;
            padding: 15px;
            border-radius: 8px;
            background-color: var(--reveal-bg);
            border: 1px dashed var(--info-color);
            text-align: left;
            display: none;
        }

        #drug-mastery-quiz #answerFeedback h5 {
            margin-top: 0;
            color: var(--primary-color);
            font-size: 1.1em;
        }

        #drug-mastery-quiz #masteryButtons {
            margin-top: 20px;
            display: flex;
            justify-content: space-around;
            gap: 10px;
        }

        #drug-mastery-quiz #masteryButtons button {
            flex: 1;
            padding: 12px 20px;
            border: none;
            border-radius: 8px;
            font-size: 1.1em;
            cursor: pointer;
        }
        #drug-mastery-quiz #masteryButtons button#correctBtn {
            background-color: var(--button-mastered);
            color: white;
        }
        #drug-mastery-quiz #masteryButtons button#correctBtn:hover {
            background-color: #218838;
        }
        #drug-mastery-quiz #masteryButtons button#incorrectBtn {
            background-color: var(--button-missed);
            color: white;
        }
        #drug-mastery-quiz #masteryButtons button#incorrectBtn:hover {
            background-color: #c82333;
        }

        /* Removed #nextCardBtn from quiz styles as it's now automatic */

        #drug-mastery-quiz #quizSummary {
            display: none;
            padding: 25px;
            background-color: #e6ffe6; /* Light green for success */
            border: 2px solid var(--secondary-color);
            border-radius: 10px;
            text-align: center;
        }
        #drug-mastery-quiz #quizSummary h4 {
            color: var(--secondary-color);
            font-size: 2em;
            margin-bottom: 15px;
            border-bottom: none;
        }
        #drug-mastery-quiz #quizSummary p {
            font-size: 1.2em;
            margin-bottom: 10px;
        }
        #drug-mastery-quiz #quizSummary button {
            margin: 10px;
            padding: 12px 25px;
            border-radius: 8px;
            font-size: 1.1em;
            cursor: pointer;
            border: none;
        }
        #drug-mastery-quiz #quizSummary button#restartQuizBtn {
            background-color: var(--primary-color);
            color: white;
        }
        #drug-mastery-quiz #quizSummary button#restartQuizBtn:hover {
            background-color: #0056b3;
        }
        #drug-mastery-quiz #quizSummary button#reviewMissedBtn {
            background-color: var(--alert-color);
            color: white;
        }
        #drug-mastery-quiz #quizSummary button#reviewMissedBtn:hover {
            background-color: #c82333;
        }

        #drug-mastery-quiz .progress-tracker {
            font-size: 0.9em;
            color: #666;
            margin-bottom: 15px;
        }

        /* ADHD-specific additions */
        .quick-note-area {
            background-color: #f7f7f7;
            border: 1px dashed #ccc;
            padding: 15px;
            margin: 20px 0;
            border-radius: 8px;
        }

        .quick-note-area h3 {
            color: #666;
            border-bottom: 1px solid #ddd;
            margin-top: 0;
        }

        .quick-note-area textarea {
            width: calc(100% - 10px);
            min-height: 100px;
            padding: 5px;
            border: 1px solid #ddd;
            border-radius: 4px;
            font-family: 'Open Sans', sans-serif;
            font-size: 0.95em;
            resize: vertical; /* Allow vertical resizing */
        }

        .text-size-controls {
            text-align: right;
            margin-bottom: 10px;
        }

        .text-size-controls button {
            background-color: #6c757d;
            color: white;
            border: none;
            padding: 5px 10px;
            border-radius: 4px;
            cursor: pointer;
            font-size: 0.9em;
            margin-left: 5px;
        }

        .micro-break-prompt {
            position: fixed;
            bottom: 20px;
            left: 50%;
            transform: translateX(-50%);
            background-color: var(--break-prompt-bg);
            border: 2px solid var(--break-prompt-border);
            padding: 15px 25px;
            border-radius: 10px;
            box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
            z-index: 1000;
            font-weight: bold;
            color: var(--alert-color);
            display: none; /* Hidden by default */
            animation: fadeInOut 8s forwards; /* Animation */
        }

        @keyframes fadeInOut {
            0% { opacity: 0; transform: translateX(-50%) translateY(20px); }
            10% { opacity: 1; transform: translateX(-50%) translateY(0); }
            90% { opacity: 1; transform: translateX(-50%) translateY(0); }
            100% { opacity: 0; transform: translateX(-50%) translateY(20px); }
        }

        /* Clock Out Overlay Styles (Revised for improved centering and appearance) */
        #clockOutOverlay {
            position: fixed;
            top: 0;
            left: 0;
            width: 100%;
            height: 100%;
            background-color: rgba(0, 0, 0, 0.7); /* Dark semi-transparent overlay */
            display: flex;
            justify-content: center;
            align-items: center;
            z-index: 10000; /* Make sure it's on top of everything */
            /* Start hidden and transition in */
            visibility: hidden;
            opacity: 0;
            transition: visibility 0s 0.5s, opacity 0.5s ease-out; /* Delay visibility transition for smooth fade out */
        }

        #clockOutOverlay.active {
            visibility: visible;
            opacity: 1;
            transition: visibility 0s, opacity 0.5s ease-in; /* No delay for fade in */
        }

        #clockOutContent {
            background-color: var(--bg-white);
            color: var(--text-color);
            padding: 40px;
            border-radius: 10px;
            box-shadow: 0 5px 25px rgba(0, 0, 0, 0.4);
            text-align: center;
            max-width: 400px;
            width: 90%; /* Responsive width */
            /* Add some initial transform to make it "pop" when appearing */
            transform: scale(0.9) translateY(20px);
            opacity: 0;
            transition: transform 0.5s ease-out, opacity 0.5s ease-out;
        }

        #clockOutOverlay.active #clockOutContent {
            transform: scale(1) translateY(0);
            opacity: 1;
        }

        #clockOutContent h2 {
            color: var(--primary-color);
            font-family: 'Roboto', sans-serif; /* Ensure Roboto font */
            font-size: 2.8em; /* Slightly larger for impact */
            margin-top: 0;
            border-bottom: none; /* Override default h2 border */
        }

        #brainEmoji {
            font-size: 6em; /* Make the emoji very large */
            margin: 20px 0;
            display: block; /* Ensure it takes full width for margin auto */
            animation: floatUpDown 2s infinite alternate ease-in-out; /* Gentle animation */
        }

        @keyframes floatUpDown {
            0% { transform: translateY(0); }
            100% { transform: translateY(-15px); } /* Increased float */
        }

        #countdownTimer {
            font-family: 'Roboto', monospace; /* Monospace for consistent digit width */
            font-size: 4.5em; /* Slightly larger timer */
            font-weight: 700;
            color: var(--alert-color); /* Red for urgency */
            margin: 20px 0;
        }

        /* Mobile Responsiveness for Clock Out */
        @media (max-width: 500px) {
            #clockOutContent {
                padding: 25px; /* Smaller padding on small screens */
            }
            #clockOutContent h2 {
                font-size: 2em;
            }
            #brainEmoji {
                font-size: 4em;
            }
            #countdownTimer {
                font-size: 3.5em;
            }
        }


        /* Mobile Responsiveness for overall layout */
        @media (max-width: 768px) {
            .container {
                margin: 10px;
                padding: 10px;
            }

            header h1 {
                font-size: 1.8em;
            }

            nav ul {
                flex-direction: column;
            }

            nav ul li {
                margin: 5px 0;
            }

            .prototype-drug-chart, .responsive-table {
                display: block;
                width: 100%;
                overflow-x: auto;
                -webkit-overflow-scrolling: touch;
            }

            .prototype-drug-chart thead, .responsive-table thead {
                display: none;
            }

            .prototype-drug-chart tbody tr, .responsive-table tbody tr {
                display: block;
                margin-bottom: 10px;
                border: 1px solid var(--border-color);
                border-radius: 5px;
            }

            .prototype-drug-chart tbody td, .responsive-table tbody td {
                display: block;
                text-align: right;
                padding-left: 50%;
                position: relative;
            }

            .prototype-drug-chart tbody td::before, .responsive-table tbody td::before {
                content: attr(data-label);
                position: absolute;
                left: 10px;
                width: calc(50% - 20px);
                padding-right: 10px;
                white-space: nowrap;
                text-align: left;
                font-weight: bold;
            }

            .micro-break-prompt {
                width: 90%;
                left: 5%;
                transform: translateX(0%);
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Module 42: Antihypertensives</h1>
            <p>Mastering Pharmacology for Nursing Care - ADHD Friendly!</p>
            <div id="moduleProgressBarContainer">
                <div id="moduleProgressBar"></div>
            </div>
        </header>

        <nav>
            <ul>
                <li><a id="nav-objectives">Objectives</a></li>
                <li><a id="nav-hypertension">Hypertension</a></li>
                <li><a id="nav-bp-regulators">BP Regulators</a></li>
                <li><a id="nav-risk-factors">Risk Factors</a></li>
                <li><a id="nav-cultural-responses">Cultural Responses</a></li>
                <li><a id="nav-older-adults">Older Adults</a></li>
                <li><a id="nav-nonpharmacologic">Nonpharm. Control</a></li>
                <li><a id="nav-pharmacologic-control">Pharm. Control</a></li>
                <li><a id="nav-diuretics">Diuretics</a></li>
                <li><a id="nav-sympatholytics">Sympatholytics</a></li>
                <li><a id="nav-np-beta-blockers">NP: Beta Blockers</a></li>
                <li><a id="nav-alpha-blockers">Alpha Blockers</a></li>
                <li><a id="nav-np-alpha-blockers">NP: Alpha Blockers</a></li>
                <li><a id="nav-vasodilators">Vasodilators</a></li>
                <li><a id="nav-ace-inhibitors">ACE Inhibitors</a></li>
                <li><a id="nav-np-ace-inhibitors">NP: ACE Inhibitors</a></li>
                <li><a id="nav-arbs">ARBs</a></li>
                <li><a id="nav-direct-renin-inhibitors">Direct Renin Inh.</a></li>
                <li><a id="nav-calcium-channel-blockers">CCBs</a></li>
                <li><a id="nav-critical-thinking">Case Study</a></li>
                <li><a id="nav-review-questions">Review Qs</a></li>
                <li><a id="nav-drug-mastery-quiz">Drug Challenge!</a></li>
            </ul>
        </nav>

        <div class="text-size-controls">
            <button id="increaseText">A+</button>
            <button id="decreaseText">A-</button>
        </div>

        <div class="micro-break-prompt" id="microBreakPrompt">
            Quick Break! Stand up and stretch, or take a few deep breaths!
        </div>

        <section id="objectives" class="objectives">
            <h2>Your Learning Adventure Starts Here!</h2>
            <p>By the end of this module, you'll be able to:</p>
            <ul>
                <li class="objective-item"><strong>Differentiate the pharmacologic action of the various categories of antihypertensive drugs.</strong></li>
                <li class="objective-item"><strong>Compare the side effects and adverse reactions to sympatholytics, direct-acting vasodilators, and angiotensin antagonists.</strong></li>
                <li class="objective-item"><strong>Apply the Clinical Judgment [Nursing Process] related to antihypertensives, including nursing interventions and teaching.</strong></li>
                <li class="objective-item"><strong>Describe the blood pressure guidelines for determining hypertension.</strong></li>
            </ul>
            <p class="note"><strong>Bonus!</strong> For extra info and cool tools, check out <a href="http://evolve.elsevier.com/McCuistion/pharmacology" target="_blank">evolve.elsevier.com/McCuistion/pharmacology</a></p>
        </section>

        <div class="quick-note-area">
            <h3>Quick Notes / Brain Dump Space</h3>
            <textarea id="quickNotesTextarea" placeholder="Jot down thoughts, questions, or key takeaways here... (Note: These will try to save to your browser's local storage, but backup important info!)"></textarea>
        </div>

        <section id="hypertension">
            <h2>1. Hypertension: The Silent Killer</h2>
            <div class="info-card">
                <p><span class="tooltip-container">Hypertension<span class="tooltip-text">Persistently elevated blood pressure (BP) which is the most common condition leading to myocardial infarction (MI), stroke, renal failure, and death.</span></span> is the most common condition leading to serious cardiovascular events like MI, stroke, renal failure, and death.</p>
                <p><strong>Essential Hypertension:</strong>
                    <ul>
                        <li>Affects <span class="highlight">95%</span> of persons with high blood pressure.</li>
                        <li>Exact cause is unknown.</li>
                        <li>Contributing factors: hyperlipidemia, African American race, diabetes, aging, stress, excessive alcohol, smoking, obesity (contributes to <span class="highlight">30%</span> of cases), family history.</li>
                    </ul>
                </p>
                <p><strong>Secondary Hypertension:</strong>
                    <ul>
                        <li>Accounts for <span class="highlight">5%</span> of hypertension cases.</li>
                        <li>Related to identifiable causes like renal and endocrine disorders.</li>
                    </ul>
                </p>

                <h3>Guidelines for Hypertension (JNC 8, 2017):</h3>
                <p>BP data should be based on an average of more than two readings on more than two occasions.</p>
                <ul>
                    <li><strong>Normal BP:</strong> Less than 120/80 mm Hg</li>
                    <li><strong>Elevated BP:</strong> Systolic BP (SBP) 120-129 AND Diastolic BP (DBP) less than 80 mm Hg.</li>
                    <li><strong>Stage 1 Hypertension:</strong> 130/80 to 139/89 mm Hg.</li>
                    <li><strong>Stage 2 Hypertension:</strong> 140/90 mm Hg or greater.</li>
                </ul>
                <div class="quick-fact">
                    <p>SBP is considered more important than DBP as a cardiovascular disease (CVD) risk factor.</p>
                    <p>Only approximately <span class="highlight">48%</span> of hypertensive individuals have their condition under control.</p>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Hypertension Basics</h4>
                <ul>
                    <li>Leading cause of MI, stroke, renal failure, death.</li>
                    <li>Essential HTN (95%): Unknown cause, linked to lifestyle/genetics.</li>
                    <li>Secondary HTN (5%): Due to other medical conditions.</li>
                    <li>BP Guidelines: Normal (&lt;120/80), Elevated (120-129/&lt;80), Stage 1 (130-139/80-89), Stage 2 (&ge;140/90).</li>
                    <li>Less than half of hypertensives have controlled BP.</li>
                </ul>
            </div>
        </section>

        <section id="bp-regulators">
            <h2>2. Selected Regulators of Blood Pressure: The Body's Control Systems</h2>
            <div class="info-card">
                <p>Your body has intricate systems to regulate and maintain blood pressure (BP).</p>
                <h3>Kidneys: Fluid and Renin-Angiotensin-Aldosterone System (RAAS)</h3>
                <ul>
                    <li><strong>Fluid Volume:</strong> Kidneys control sodium and water elimination and retention, directly affecting cardiac output and systemic arterial BP.</li>
                    <li><strong>RAAS:</strong> When BP decreases, renin is released from renal cells.
                        <ul>
                            <li>Renin stimulates Angiotensin II production (a potent vasoconstrictor).</li>
                            <li>Angiotensin II causes Aldosterone release (promotes sodium and water retention).</li>
                            <li>Result: Increased fluid volume, elevated BP.</li>
                        </ul>
                    </li>
                </ul>
                <div class="figure-placeholder">
                    FIGURE 42.1 The Renin-Angiotensin-Aldosterone System (RAAS) (Not displayed here).
                </div>
                <h3>Neural and Hormonal Regulators:</h3>
                <ul>
                    <li><strong>Baroreceptors:</strong> Located in the aorta and carotid sinus, they sense changes in BP.</li>
                    <li><strong>Vasomotor Center:</strong> In the medulla, controls vasoconstriction/vasodilation.</li>
                    <li><strong>Catecholamines (Norepinephrine, Epinephrine):</strong> Released by sympathetic nerves and adrenal medulla, increase BP via vasoconstriction.</li>
                    <li><strong>Antidiuretic Hormone (ADH):</strong> From posterior pituitary, stimulates kidneys to conserve water during fluid deficit, increasing BP. Inhibited during fluid overload.</li>
                </ul>
            </div>
            <div class="recap">
                <h4>Recap: BP Regulators</h4>
                <ul>
                    <li>Kidneys: Regulate fluid volume, manage RAAS (Renin -> Angiotensin II -> Aldosterone -> Na+/H2O retention -> increased BP).</li>
                    <li>Baroreceptors/Vasomotor Center: Neural control.</li>
                    <li>Catecholamines: Increase BP via vasoconstriction.</li>
                    <li>ADH: Conserves water, raises BP during fluid deficit.</li>
                </ul>
            </div>
        </section>

        <section id="risk-factors">
            <h2>3. Physiologic Risk Factors & Hypertension</h2>
            <div class="info-card">
                <p>Beyond genetics and race, certain lifestyle and physiological factors significantly contribute to hypertension:</p>
                <ul>
                    <li><strong>Diet:</strong> High intake of saturated fat and simple carbohydrates can increase BP.</li>
                    <li><strong>Alcohol:</strong> Increases renin secretions, leading to more angiotensin II and higher BP.</li>
                    <li><strong>Obesity:</strong> Affects sympathetic and cardiovascular systems by increasing cardiac output, stroke volume, and left ventricular filling. <span class="highlight">Two-thirds of hypertensive persons are obese.</span></li>
                </ul>
                <button class="reveal-button">Positive Impact of Lifestyle Changes</button>
                <div class="reveal-content">
                    <p>Even mild to moderate interventions can help:</p>
                    <ul>
                        <li><strong>Weight loss:</strong> Can significantly decrease hypertension.</li>
                        <li><strong>Sodium restriction:</strong> Can lower BP.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Risk Factors</h4>
                <ul>
                    <li>Diet: High saturated fat/simple carbs.</li>
                    <li>Alcohol: Increases renin.</li>
                    <li>Obesity: Increases cardiac workload.</li>
                    <li>Weight loss & sodium restriction can help.</li>
                </ul>
            </div>
        </section>

        <section id="cultural-responses">
            <h2>4. Cultural Responses to Antihypertensive Agents</h2>
            <div class="info-card">
                <p>It's crucial for nurses to understand that response to antihypertensive drugs can vary significantly across different cultural and racial groups.</p>
                <ul>
                    <li><strong>African Americans:</strong>
                        <ul>
                            <li>More likely to develop hypertension at an earlier age than Caucasians.</li>
                            <li>Have a higher mortality rate from hypertension than the Caucasian population.</li>
                            <li><span class="highlight">Less effective response</span> to beta-adrenergic blockers (beta blockers) and ACE inhibitors *unless* combined with a diuretic.</li>
                            <li>Often have <span class="highlight">low-renin hypertension</span>, which explains their poorer response to beta blockers and ACE inhibitors.</li>
                            <li>Respond well to <span class="highlight">alpha1 blockers</span>, <span class="highlight">calcium channel blockers (CCBs)</span>, and <span class="highlight">diuretics</span> as initial monotherapy.</li>
                        </ul>
                    </li>
                    <li><strong>Caucasian Patients:</strong>
                        <ul>
                            <li>Usually have <span class="highlight">high-renin hypertension</span>.</li>
                            <li>Generally respond well to <span class="highlight">all antihypertensive agents</span>.</li>
                        </ul>
                    </li>
                    <li><strong>Asian Americans:</strong>
                        <ul>
                            <li>Approximately <span class="highlight">twice as sensitive</span> as Caucasians to beta blockers and other antihypertensives.</li>
                            <li>Often require a <span class="highlight">reduction in antihypertensive dosing</span>.</li>
                        </ul>
                    </li>
                    <li><strong>Native Americans:</strong>
                        <ul>
                            <li>Have a <span class="highlight">reduced or lower response</span> to beta blockers compared with Caucasians.</li>
                        </ul>
                    </li>
                </ul>
                <div class="note">
                    <p>Ongoing monitoring of BP and drug dosing is essential for patients in all cultural groups to ensure optimal and safe treatment.</p>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Cultural Responses</h4>
                <ul>
                    <li>African Americans: Higher prevalence/mortality. Less effective response to beta blockers/ACEIs (unless with diuretic); respond well to alpha1 blockers, CCBs, diuretics. Often low-renin.</li>
                    <li>Caucasians: Usually high-renin, respond well to all.</li>
                    <li>Asian Americans: Twice as sensitive to beta blockers/other antihypertensives; often need lower doses.</li>
                    <li>Native Americans: Reduced response to beta blockers.</li>
                    <li>Individualized monitoring is key for all groups.</li>
                </ul>
            </div>
        </section>

        <section id="older-adults">
            <h2>5. Hypertension in Older Adults</h2>
            <div class="info-card">
                <p>Hypertension is highly prevalent in older adults:</p>
                <ul>
                    <li>Approximately <span class="highlight">70 million American adults</span> have hypertension, representing <span class="highlight">46%</span> of the adult population.</li>
                    <li>Of individuals over 60 years of age, <span class="highlight">65%</span> (or <span class="highlight">two in three</span> people) have developed hypertension.</li>
                    <li>Only about <span class="highlight">48%</span> of hypertensive individuals have their condition under control.</li>
                    <li>Males aged 18-49 typically have a higher prevalence of hypertension than females in that age range.</li>
                </ul>
                <p>Antihypertensive therapy can significantly reduce cardiovascular disorders: <span class="highlight">34% decrease in stroke</span> and <span class="highlight">19% decrease in coronary heart disease</span>.</p>

                <h3>Orthostatic Hypotension: A Key Concern in Older Adults</h3>
                <p>One troublesome side effect of antihypertensive agents in older adults, especially frail or institutionalized persons, is <span class="highlight">orthostatic (postural) hypotension</span>. This is a sudden drop in BP upon standing, causing dizziness due to blood pooling in the lower extremities.</p>
                <div class="note">
                    <p>In older adults, the sympathetic nervous system may not respond as quickly to correct orthostatic hypotension, particularly when potentiated by antihypertensive drugs. The drug dose may need to be decreased or another drug used.</p>
                </div>
                <p><strong>Lifestyle modifications for older adults with hypertension:</strong></p>
                <ul>
                    <li>Restrict dietary sodium to 2400 mg daily.</li>
                    <li>Avoid tobacco.</li>
                    <li>Modify diet (e.g., DASH diet).</li>
                    <li>Engage in exercise.</li>
                    <li>Decrease stress.</li>
                </ul>
            </div>
            <div class="recap">
                <h4>Recap: HTN in Older Adults</h4>
                <ul>
                    <li>Very common: 65% of those >60 have HTN (2 in 3).</li>
                    <li>Therapy reduces stroke (34%) and CHD (19%).</li>
                    <li>Key concern: Orthostatic hypotension (due to slower sympathetic response).</li>
                    <li>Lifestyle modifications are vital: low sodium, no tobacco, diet, exercise, stress reduction.</li>
                </ul>
            </div>
        </section>

        <section id="nonpharmacologic">
            <h2>6. Nonpharmacologic Control of Hypertension: First Steps</h2>
            <div class="info-card">
                <p>Significant reductions in blood pressure can often be achieved through nonpharmacologic methods. These methods should be the first line of approach, especially for mild hypertension.</p>
                <div class="note">
                    <p>However, if systolic BP is greater than 140 mm Hg, antihypertensive drugs are generally ordered in combination with these nonpharmacologic strategies.</p>
                </div>
                <h3>Key Nonpharmacologic Strategies:</h3>
                <ul>
                    <li>Stress-reduction techniques.</li>
                    <li>Regular exercise.</li>
                    <li>Salt restriction.</li>
                    <li>Decreased alcohol ingestion.</li>
                    <li>Smoking cessation.</li>
                </ul>
            </div>
            <div class="recap">
                <h4>Recap: Nonpharmacologic HTN Control</h4>
                <ul>
                    <li>First approach for mild HTN.</li>
                    <li>Always combine with drugs if SBP > 140 mm Hg.</li>
                    <li>Strategies: Stress reduction, exercise, salt restriction, less alcohol, no smoking.</li>
                </ul>
            </div>
        </section>

        <section id="pharmacologic-control">
            <h2>7. Pharmacologic Control of Hypertension: The Drug Arsenal</h2>
            <div class="info-card">
                <p>Pharmacologic control of hypertension involves an individualized approach by healthcare providers, emphasizing the lowest effective doses and often using combination therapy to minimize adverse effects.</p>
                <h3>Antihypertensive Drug Categories:</h3>
                <p>Used singly or in combination, these drugs fall into seven main categories:</p>
                <ol>
                    <li>Diuretics</li>
                    <li>Sympatholytics (Sympathetic Depressants)</li>
                    <li>Direct-Acting Arteriolar Vasodilators</li>
                    <li>Angiotensin-Converting Enzyme (ACE) Inhibitors</li>
                    <li>Angiotensin II–Receptor Blockers (ARBs)</li>
                    <li>Direct Renin Inhibitors</li>
                    <li>Calcium Channel Blockers (CCBs)</li>
                </ol>
            </div>
            <div class="recap">
                <h4>Recap: Pharmacologic HTN Control</h4>
                <ul>
                    <li>Individualized approach, low effective doses.</li>
                    <li>Often combination therapy.</li>
                    <li>7 main categories: Diuretics, Sympatholytics, Direct Vasodilators, ACEIs, ARBs, Direct Renin Inhibitors, CCBs.</li>
                </ul>
            </div>
        </section>

        <section id="diuretics">
            <h2>8. Diuretics: First-Line for Mild Hypertension</h2>
            <div class="info-card">
                <p>Diuretics are effective as <span class="highlight">first-line drugs for treating mild hypertension</span> because they promote sodium depletion, which decreases extracellular fluid volume (ECFV).</p>
                <ul>
                    <li><strong>Hydrochlorothiazide (HCTZ):</strong> Most frequently prescribed diuretic for mild hypertension. Can be used alone or with other antihypertensive drugs.</li>
                    <li>Many antihypertensive drugs can cause fluid retention, so diuretics are often co-administered.</li>
                </ul>
                <div class="note">
                    <p><strong>Thiazide diuretics are NOT recommended for patients with renal insufficiency</strong> (creatinine clearance <30 mL/min). In such cases, <span class="highlight">loop (high-ceiling) diuretics</span> like furosemide are preferred as they do not depress renal blood flow.</p>
                </div>
                <div class="quick-fact">
                    <p>Loop diuretics are generally not used if hypertension is due to RAAS involvement, as they can immediately elevate serum renin levels.</p>
                    <p>Combinations of potassium-wasting (e.g., thiazides) and potassium-sparing diuretics can minimize potassium loss while enhancing the diuretic effect.</p>
                    <p>ACE inhibitors, when combined with a thiazide diuretic, help minimize serum potassium loss because ACE inhibitors tend to increase serum potassium levels.</p>
                </div>
                <button class="reveal-button">Common Thiazide Combinations</button>
                <div class="reveal-content">
                    <h4>Combinations of Thiazides with Other Antihypertensive Drugs:</h4>
                    <ul>
                        <li><strong>Thiazide With Potassium-Sparing Diuretics:</strong> Hydrochlorothiazide with spironolactone, amiloride, or triamterene.</li>
                        <li><strong>Thiazide With Beta Blockers:</strong> Hydrochlorothiazide with bisoprolol fumarate, metoprolol, or bendroflumethiazide with nadolol. (e.g., Tenoretic = Chlorthalidone with atenolol)</li>
                        <li><strong>Thiazide With Angiotensin-Converting Enzyme Inhibitors:</strong> Hydrochlorothiazide with benazepril, captopril, enalapril maleate, fosinopril, lisinopril, moexipril, or quinapril.</li>
                        <li><strong>Thiazide With Angiotensin II Antagonists (ARBs):</strong> Hydrochlorothiazide with candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, or valsartan.</li>
                        <li><strong>Thiazide With Centrally Acting Alpha2 Agonist:</strong> Chlorthalidone with clonidine, or Hydrochlorothiazide with methyldopa.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Diuretics for HTN</h4>
                <ul>
                    <li>First-line for mild HTN (e.g., HCTZ).</li>
                    <li>Promote Na+ depletion, decrease ECFV.</li>
                    <li>Thiazides: Not for renal insufficiency.</li>
                    <li>Loop diuretics: Preferred for renal insufficiency, but not RAAS HTN.</li>
                    <li>Often combined with other antihypertensives to reduce fluid retention and balance K+ levels.</li>
                </ul>
            </div>
        </section>

        <section id="sympatholytics">
            <h2>9. Sympatholytics (Sympathetic Depressants): Quieting the System</h2>
            <div class="info-card">
                <p>Sympatholytics reduce sympathetic nervous system activity, leading to lower blood pressure. There are five groups:</p>
                <ol>
                    <li>Beta-Adrenergic Blockers</li>
                    <li>Centrally Acting Alpha2 Agonists</li>
                    <li>Alpha-Adrenergic Blockers</li>
                    <li>Adrenergic Neuron Blockers (Peripherally Acting)</li>
                    <li>Alpha1- and Beta1-Adrenergic Blockers</li>
                </ol>

                <h3>Beta-Adrenergic Blockers (Beta Blockers)</h3>
                <p>Beta blockers reduce cardiac output by diminishing the sympathetic nervous system response, leading to decreased heart rate, contractility, and renin release. This lowers BP.</p>
                <div class="note">
                    <p>African American hypertensive patients typically do NOT respond well to beta blockers alone. Combination with diuretics is often needed for effective BP control in this population.</p>
                </div>
                <h4>Types of Beta Blockers:</h4>
                <ul>
                    <li><strong>Nonselective Beta Blockers (e.g., Propranolol, Carvedilol):</strong> Inhibit beta1 (heart) and beta2 (bronchial) receptors. Slows HR, decreases BP, but can cause <span class="highlight">bronchoconstriction</span>. Should not be given to patients with COPD.</li>
                    <li><strong>Cardioselective Beta Blockers (e.g., Acebutolol, Atenolol, Metoprolol):</strong> Primarily act on beta1 receptors, decreasing HR and BP with less risk of bronchoconstriction. Preferred.</li>
                </ul>
                <div class="patient-safety">
                    <h4>Critical Warning!</h4>
                    <p>Beta blockers should NOT be abruptly discontinued! Tapering the dose over 1-2 weeks is crucial to prevent <span class="highlight">rebound hypertension</span>, angina, dysrhythmias, and MI.</p>
                </div>
                <table class="prototype-drug-chart responsive-table">
                    <thead>
                        <tr>
                            <th>Drug Class</th>
                            <th>Dosage</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td data-label="Drug Class">Antihypertensive: beta1 blocker</td>
                            <td data-label="Dosage">
                                Hypertension:<br>
                                Regular release: A: PO: Initially 100 mg/d in divided doses; maint: 100–450 mg in divided doses; max: 450 mg/d in divided doses<br>
                                Extended release: A: PO: 25–100 mg/d; max: 400 mg/d
                            </td>
                        </tr>
                        <tr>
                            <th colspan="2">Watch Out For! (Contraindications & Interactions)</th>
                        </tr>
                        <tr>
                            <td data-label="Contraindications" colspan="2">
                                Hypersensitivity, heart block, cardiogenic shock, hypotension, acute HF, bradycardia<br>
                                <strong>Caution:</strong> Hepatic or thyroid dysfunction, asthma, peripheral vascular disease, diabetes mellitus, COPD, cerebrovascular disease, depression
                            </td>
                        </tr>
                        <tr>
                            <td data-label="Drug-Lab-Food Interactions" colspan="2">
                                <strong>Increases bradycardia and heart block with:</strong> digitalis, clonidine, SSRIs, MAOIs, cimetidine; <strong>increased hypotensive effect with:</strong> other antihypertensives, alcohol, anesthetics; <strong>NSAIDs decrease effect of beta blockers.</strong><br>
                                <strong>Lab:</strong> Increased hepatic enzymes
                            </td>
                        </tr>
                        <tr>
                            <th>How it Moves (Pharmacokinetics)</th>
                            <th>How it Works (Pharmacodynamics)</th>
                        </tr>
                        <tr>
                            <td data-label="Pharmacokinetics">
                                <strong>Absorption:</strong> PO: 95%<br>
                                <strong>Distribution:</strong> PB: 10%–12%<br>
                                <strong>Metabolism:</strong> t½: 3–7 h<br>
                                <strong>Excretion:</strong> In urine
                            </td>
                            <td data-label="Pharmacodynamics">
                                <strong>Immediate release: PO:</strong> Onset: 30–60 min; Peak: 1–2 h; Duration: 6.4 h<br>
                                <strong>Extended release: PO:</strong> Onset UK; Peak: 7 h; Duration: 24 h<br>
                                <strong>Therapeutic Effects/Uses:</strong> To control hypertension, acute myocardial infarction, angina, and HF<br>
                                <strong>Mechanism of Action:</strong> Promotes blood pressure reduction via a beta1-blocking effect.
                            </td>
                        </tr>
                        <tr>
                            <th>Side Effects</th>
                            <th>Adverse Reactions</th>
                        </tr>
                        <tr>
                            <td data-label="Side Effects">Fatigue, dizziness, dysgeusia, dry mouth, nausea, vomiting, diarrhea, insomnia, nightmares, drowsiness, headache, blurred vision, rash, pruritus, peripheral edema, tinnitus, erectile dysfunction, depression</td>
                            <td data-label="Adverse Reactions">Bradycardia, hypotension, palpitations, stroke, thrombocytopenia, diabetes mellitus<br>
                                <strong>Life-threatening:</strong> Dysrhythmias, bronchospasm, agranulocytosis, HF
                            </td>
                        </tr>
                    </tbody>
                </table>
                <button class="reveal-button">More on Beta Blocker Side Effects</button>
                <div class="reveal-content">
                    <ul>
                        <li>Decreased pulse rate, markedly decreased BP.</li>
                        <li>Dizziness, insomnia, depression, fatigue, nightmares, erectile dysfunction.</li>
                        <li>Use with caution in patients with diabetes mellitus (can inhibit the liver's ability to convert glycogen to glucose in response to hypoglycemia).</li>
                    </ul>
                </div>

                <h3>Centrally Acting Alpha2 Agonists</h3>
                <p>These drugs (e.g., Clonidine, Methyldopa) decrease sympathetic activity from the brainstem to peripheral vessels. They reduce peripheral vascular resistance and cause vasodilation by:</p>
                <ul>
                    <li>Stimulating alpha2 receptors.</li>
                    <li>Decreasing cardiac output.</li>
                    <li>Decreasing serum epinephrine, norepinephrine, and renin release.</li>
                </ul>
                <div class="note">
                    <p>Beta blockers are NOT given with centrally acting sympatholytics due to increased bradycardia and rebound hypertension upon discontinuation.</p>
                </div>
                <p>Clonidine is available in a transdermal patch (7-day duration). Methyldopa is often used for chronic or pregnancy-induced hypertension, but crosses the placental barrier.</p>
                <button class="reveal-button">Centrally Acting Alpha2 Agonists Side Effects</button>
                <div class="reveal-content">
                    <ul>
                        <li>Drowsiness, dry mouth, dizziness, slow heart rate (bradycardia).</li>
                        <li>Can cause sodium and water retention (peripheral edema); often given with diuretics.</li>
                        <li>Methyldopa: Should not be used in impaired liver function; monitor liver enzymes.</li>
                    </ul>
                    <div class="patient-safety">
                        <h4>Rebound Hypertension Risk!</h4>
                        <p>This group of drugs must NOT be abruptly discontinued! A severe rebound hypertensive crisis (restlessness, tachycardia, tremors, headache, increased BP) can result. Guanfacine has a lower risk of this rebound effect.</p>
                    </div>
                </div>
                <div class="quick-fact">
                    <h4>Herbal Interactions with Antihypertensives!</h4>
                    <ul>
                        <li>Ma-huang (Ephedra): Decreases/counteracts antihypertensive effects; increases HTN with beta blockers.</li>
                        <li>Black cohosh, Goldenseal, Coleus: May increase hypotensive effect.</li>
                        <li>Hawthorn: May increase beta blocker and ACEI effects.</li>
                        <li>Licorice, Korean ginseng, Milk thistle: Decrease antihypertensive effects.</li>
                        <li>Cayenne: May cause cough with ACEIs.</li>
                        <li>Chinese skullcap: May increase losartan levels.</li>
                        <li>St. John’s wort: Decreases CCB effects (nifedipine, verapamil).</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Sympatholytics</h4>
                <ul>
                    <li>Reduce sympathetic activity.</li>
                    <li>Beta Blockers: Reduce HR, contractility, renin release. Less effective alone in African Americans. DON'T STOP ABRUPTLY (rebound HTN!). Cardioselective preferred.</li>
                    <li>Centrally Acting Alpha2 Agonists (Clonidine, Methyldopa): Decrease sympathetic outflow, cardiac output. Cause drowsiness, dry mouth, fluid retention. DON'T STOP ABRUPTLY (rebound HTN!).</li>
                    <li>Many herbal interactions.</li>
                </ul>
            </div>
        </section>

        <section id="np-beta-blockers">
            <h2>10. Clinical Judgment: Nursing Process - Antihypertensives: Beta Blockers</h2>
            <div class="info-card">
                <p>Our core concept here is: <span class="highlight">Perfusion</span>.</p>
                <button class="reveal-button">Your Nursing Superpowers: Assessment to Evaluation!</button>
                <div class="reveal-content">
                    <h3>Recognize Cues [Assessment]: What do you notice?</h3>
                    <ul>
                        <li><strong>Medication and Herbal History:</strong> Identify all current drugs and supplements. Report potential drug-drug or drug-herbal interactions.</li>
                        <li><strong>Vital Signs:</strong> Obtain baseline BP and pulse. Report abnormal findings and compare with baseline (especially bradycardia).</li>
                        <li><strong>Laboratory Values:</strong> Periodically check renal and liver function (BUN, serum creatinine, AST, LDH).</li>
                    </ul>

                    <h3>Analyze Cues and Prioritize Hypothesis [Patient Problems]: What's the biggest issue?</h3>
                    <ul>
                        <li>Hypertension</li>
                        <li>Fatigue</li>
                        <li>Bradycardia</li>
                        <li>Risk for rebound hypertension</li>
                        <li>Sexual dysfunction</li>
                    </ul>

                    <h3>Generate Solutions [Planning]: What's the goal?</h3>
                    <ul>
                        <li>The patient’s BP will be 120/80 or below.</li>
                        <li>The patient will take medication as prescribed.</li>
                    </ul>

                    <h3>Take Action [Nursing Interventions]: What do YOU do?</h3>
                    <ul>
                        <li><strong>Monitor Vital Signs:</strong> Especially BP and pulse.</li>
                        <li><strong>Monitor Laboratory Results:</strong> Especially BUN, serum creatinine, AST, and LDH.</li>
                    </ul>

                    <h3>Patient Teaching: Empowering Your Patient!</h3>
                    <h4>General:</h4>
                    <ul>
                        <li><strong>Compliance:</strong> Encourage strict adherence to the drug regimen. Advise that abrupt discontinuation may cause rebound hypertension.</li>
                        <li><strong>Herbals:</strong> Inform patients that herbs can interfere with beta blockers.</li>
                        <li><strong>OTC Drugs:</strong> Advise avoiding OTC drugs (cold, cough, allergy meds) without consulting provider, as many carry warnings for hypertensive patients.</li>
                        <li><strong>Safety ID:</strong> Suggest wearing a MedicAlert bracelet or carrying a card.</li>
                        <li><strong>Trauma Situations:</strong> Teach patients to inform healthcare providers about beta blocker use in trauma, as these drugs block compensatory effects to shock (Glucagon may be needed to reverse effects).</li>
                    </ul>
                    <h4>Self-Administration:</h4>
                    <ul>
                        <li>Teach patients or family how to take radial pulse and BP, and to report abnormal findings.</li>
                    </ul>
                    <h4>Side Effects:</h4>
                    <ul>
                        <li><strong>Orthostatic Hypotension:</strong> Advise that dizziness may occur; warn to rise slowly from lying/sitting to standing.</li>
                        <li><strong>Report Symptoms:</strong> Advise reporting dizziness, slow pulse rate, BP changes, heart palpitations, confusion, or GI upset.</li>
                        <li><strong>Diabetes Mellitus:</strong> Alert patients with diabetes to possible hypoglycemic symptoms (beta blockers can mask these).</li>
                        <li><strong>Sexual Dysfunction:</strong> Inform male patients that impotence may occur (report to provider).</li>
                    </ul>
                    <h4>Diet:</h4>
                    <ul>
                        <li><strong>Nonpharmacologic Methods:</strong> Teach nonpharmacologic methods to decrease BP (low-salt diet, relaxation, exercise, smoking cessation, decreased alcohol).</li>
                        <li><strong>Constipation:</strong> Advise reporting constipation. Suggest high-fiber foods, stool softener, increased water (unless contraindicated in HF).</li>
                    </ul>

                    <h3>Evaluate Outcomes [Evaluation]: Did it work?</h3>
                    <ul>
                        <li>Evaluate effectiveness (decreased BP, absence of side effects).</li>
                        <li>Determine patient adherence to the drug regimen.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: NP - Beta Blockers</h4>
                <ul>
                    <li><strong>Assess:</strong> Med/herb history, VS (BP, pulse), renal/liver labs.</li>
                    <li><strong>Problems:</strong> HTN, fatigue, bradycardia, rebound HTN risk, sexual dysfunction.</li>
                    <li><strong>Goals:</strong> BP &le;120/80, med compliance.</li>
                    <li><strong>Intervene:</strong> Monitor VS/labs.</li>
                    <li><strong>Teach:</strong> Adherence (no abrupt stop!), avoid OTCs/certain herbs. MedicAlert. Trauma awareness. Self-monitor BP/pulse. Rise slowly. Report dizziness, slow pulse, sexual dysfunction. Nonpharm. methods. Manage constipation.</li>
                    <li><strong>Evaluate:</strong> BP control, side effect absence, compliance.</li>
                </ul>
            </div>
        </section>

        <section id="alpha-blockers">
            <h2>11. Alpha-Adrenergic Blockers: Vasodilation & Lipid Benefits</h2>
            <div class="info-card">
                <p>Alpha-adrenergic blockers (alpha blockers) block alpha-adrenergic receptors, leading to <span class="highlight">vasodilation</span> and decreased BP. They help maintain renal blood flow.</p>
                <h4>Key Benefits:</h4>
                <ul>
                    <li>Useful for hypertension in patients with <span class="highlight">lipid abnormalities</span>: Decrease VLDL and LDL, increase HDL levels.</li>
                    <li>Safe for patients with diabetes as they <span class="highlight">do not affect glucose metabolism</span>.</li>
                    <li>Do not affect respiratory function.</li>
                </ul>
                <div class="patient-safety">
                    <p>Nonselective alpha-adrenergic blockers (e.g., phenoxybenzamine, phentolamine) should NOT be given to patients with coronary artery disease due to stimulating effects and increased myocardial oxygen demand.</p>
                </div>
                <h3>Selective Alpha1-Adrenergic Blockers:</h3>
                <ul>
                    <li>Prazosin, Terazosin, Doxazosin.</li>
                    <li>Used to reduce BP and can treat <span class="highlight">benign prostatic hypertrophy (BPH)</span>.</li>
                    <li>Prazosin is common. Terazosin and doxazosin have longer half-lives (once daily at bedtime).</li>
                </ul>
                <div class="note">
                    <p>These drugs, like centrally acting alpha2 agonists, can cause sodium and water retention leading to edema. Diuretics are frequently given concomitantly.</p>
                </div>
                <table class="prototype-drug-chart responsive-table">
                    <thead>
                        <tr>
                            <th>Drug Class</th>
                            <th>Dosage</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td data-label="Drug Class">Antihypertensive: Alpha-adrenergic blocker</td>
                            <td data-label="Dosage">
                                A: PO: Initially 1 mg bid/tid; maint: 6–15 mg/d; max: 20 mg/d in divided doses<br>
                                Older A: PO: Initially 1 mg qd/bid; max: 20 mg/d
                            </td>
                        </tr>
                        <tr>
                            <th colspan="2">Watch Out For! (Contraindications & Interactions)</th>
                        </tr>
                        <tr>
                            <td data-label="Contraindications" colspan="2">
                                Hypersensitivity<br>
                                <strong>Caution:</strong> Angina, orthostatic hypotension, syncope, ocular surgery, priapism, older adults, pregnancy, breastfeeding
                            </td>
                        </tr>
                        <tr>
                            <td data-label="Drug-Lab-Food Interactions" colspan="2">
                                <strong>Increased hypotensive effect with:</strong> other antihypertensives, nitrates, diuretics, alcohol; <strong>decreased effects with:</strong> NSAIDs<br>
                                <strong>Lab:</strong> Increased hepatic enzymes
                            </td>
                        </tr>
                        <tr>
                            <th>How it Moves (Pharmacokinetics)</th>
                            <th>How it Works (Pharmacodynamics)</th>
                        </tr>
                        <tr>
                            <td data-label="Pharmacokinetics">
                                <strong>Absorption:</strong> GI: 60% (5% to circulation)<br>
                                <strong>Distribution:</strong> PB: 97%<br>
                                <strong>Metabolism:</strong> t½: 2–4 h<br>
                                <strong>Excretion:</strong> In bile and feces, 10% in urine
                            </td>
                            <td data-label="Pharmacodynamics">
                                <strong>PO:</strong> Onset: 0.5–2 h; Peak: 2–4 h; Duration: <24 h<br>
                                <strong>Therapeutic Effects/Uses:</strong> To control hypertension<br>
                                <strong>Mechanism of Action:</strong> Dilates peripheral blood vessels by blocking alpha-adrenergic receptors.
                            </td>
                        </tr>
                        <tr>
                            <th>Side Effects</th>
                            <th>Adverse Reactions</th>
                        </tr>
                        <tr>
                            <td data-label="Side Effects">Dizziness, drowsiness, blurred vision, anxiety, fatigue, weakness, headache, nasal congestion, depression, syncope, dry mouth, nausea, vomiting, diarrhea, abdominal pain, rash, constipation, peripheral edema, erectile dysfunction, urinary frequency/incontinence, edema, weakness</td>
                            <td data-label="Adverse Reactions">Orthostatic hypotension, palpitations, tachycardia, pancreatitis, elevated liver enzymes, dyspnea</td>
                        </tr>
                    </tbody>
                </table>
                <button class="reveal-button">Side Effects and Adverse Reactions</button>
                <div class="reveal-content">
                    <ul>
                        <li><span class="highlight">Orthostatic hypotension</span> (dizziness, faintness, lightheadedness, increased heart rate): May occur with the first dose.</li>
                        <li>Nausea, headache, drowsiness, nasal congestion, edema, weight gain.</li>
                        <li>Impotence (male patients, with high doses).</li>
                        <li>Drug interactions: Enhanced hypotension with alcohol, other antihypertensives, nitrates, diuretics. Decreased effect with NSAIDs.</li>
                    </ul>
                </div>

                <h3>Adrenergic Neuron Blockers (Peripherally Acting Sympatholytics)</h3>
                <p>These potent drugs (e.g., Reserpine) block norepinephrine release from sympathetic nerve endings, decreasing both cardiac output and peripheral vascular resistance, thus lowering BP. They are considered the <span class="highlight">last choices for chronic hypertension</span> due to significant side effects.</p>
                <ul>
                    <li>Common side effect: Orthostatic hypotension (rise slowly!).</li>
                    <li>Reserpine can cause pseudoparkinsonism, nightmares, and suicidal ideation.</li>
                    <li>Can cause sodium and water retention; may be taken with a diuretic.</li>
                </ul>

                <h3>Alpha1- and Beta1-Adrenergic Blockers</h3>
                <p>This group (e.g., Labetalol) blocks both alpha1 and beta1 receptors.</p>
                <ul>
                    <li>Alpha1 blockade: Causes vasodilation, decreasing peripheral resistance and BP. (Stronger effect on alpha than beta).</li>
                    <li>Beta1 blockade: Decreases heart rate and AV contractility.</li>
                    <li>Large doses can block beta2 receptors, increasing airway resistance; use with caution in severe asthma.</li>
                </ul>
                <button class="reveal-button">Alpha/Beta Blocker Side Effects</button>
                <div class="reveal-content">
                    <ul>
                        <li>Orthostatic hypotension, dizziness, paresthesia.</li>
                        <li>Nasal congestion, nausea, fatigue.</li>
                        <li>Large doses of labetalol may cause AV heart block.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Alpha Blockers & Other Sympatholytics</h4>
                <ul>
                    <li>Alpha Blockers: Vasodilate, decrease BP. Good for lipid abnormalities (decrease VLDL/LDL, increase HDL). Don't affect glucose/respiratory function. Watch for first-dose orthostatic hypotension.</li>
                    <li>Adrenergic Neuron Blockers (Reserpine): Block NE release. Last resort for HTN. Severe orthostatic hypotension, pseudoparkinsonism, suicidal ideation.</li>
                    <li>Alpha/Beta Blockers (Labetalol): Block both alpha1 (vasodilation) and beta1 (decreased HR/contractility). Caution in severe asthma.</li>
                    <li>All Sympatholytics have risk for orthostatic hypotension and may cause fluid retention.</li>
                </ul>
            </div>
        </section>

        <section id="np-alpha-blockers">
            <h2>12. Clinical Judgment: Nursing Process - Antihypertensives: Alpha-Adrenergic Blockers</h2>
            <div class="info-card">
                <p>Our core concept here is: <span class="highlight">Perfusion</span>.</p>
                <button class="reveal-button">Your Nursing Superpowers: Assessment to Evaluation!</button>
                <div class="reveal-content">
                    <h3>Recognize Cues [Assessment]: What do you notice?</h3>
                    <ul>
                        <li><strong>Medication History:</strong> Obtain a complete drug and herbal history. Report potential interactions (prazosin is highly protein bound).</li>
                        <li><strong>Baseline Vital Signs & Weight:</strong> Obtain for future comparisons.</li>
                        <li><strong>Urinary Output:</strong> Check and report if decreased (<600 mL/day), as the drug is contraindicated in renal disease.</li>
                    </ul>

                    <h3>Analyze Cues and Prioritize Hypothesis [Patient Problems]: What's the biggest issue?</h3>
                    <ul>
                        <li>Hypertension</li>
                        <li>Fatigue</li>
                        <li>Orthostatic hypotension</li>
                        <li>Edema</li>
                        <li>Sexual dysfunction</li>
                    </ul>

                    <h3>Generate Solutions [Planning]: What's the goal?</h3>
                    <ul>
                        <li>The patient’s blood pressure (BP) will decrease to 120/80 or below.</li>
                        <li>The patient will follow the proper drug regimen.</li>
                    </ul>

                    <h3>Take Action [Nursing Interventions]: What do YOU do?</h3>
                    <ul>
                        <li><strong>Monitor Vital Signs:</strong> BP and pulse. The full therapeutic effect of prazosin may take up to 4 weeks. Report sudden marked decreases in BP and tachycardia.</li>
                        <li><strong>Fluid Retention:</strong> Check daily for fluid retention in extremities and weight gain (prazosin can cause sodium and water retention).</li>
                    </ul>

                    <h3>Patient Teaching: Empowering Your Patient!</h3>
                    <h4>General:</h4>
                    <ul>
                        <li><strong>Adherence:</strong> Advise strict adherence. Abrupt discontinuation can cause rebound hypertension.</li>
                        <li><strong>Orthostatic Hypotension:</strong> Inform patients it may occur (especially with first dose). Teach to sit and dangle feet before rising. Taking drugs at bedtime may help.</li>
                        <li><strong>Daily Weights:</strong> Teach self-monitoring (prazosin can lead to edema).</li>
                    </ul>
                    <h4>Self-Administration:</h4>
                    <ul>
                        <li>Teach patients/family how to take and record BP. Establish a BP chart and report changes.</li>
                    </ul>
                    <h4>Side Effects:</h4>
                    <ul>
                        <li><strong>Common Symptoms:</strong> Caution about dizziness, lightheadedness, drowsiness, especially when starting the drug. Notify provider if these persist.</li>
                        <li><strong>Sexual Dysfunction:</strong> Inform male patients that impotence may occur (report to provider).</li>
                        <li><strong>Edema:</strong> Tell patients to report morning edema (sign of water retention).</li>
                        <li><strong>OTC Drugs:</strong> Inform patients not to take OTC cold, cough, or allergy medications without provider contact.</li>
                    </ul>
                    <h4>Diet:</h4>
                    <ul>
                        <li><strong>Salt Intake:</strong> Encourage decreased salt intake, unless otherwise indicated.</li>
                    </ul>

                    <h3>Evaluate Outcomes [Evaluation]: Did it work?</h3>
                    <ul>
                        <li>Evaluate drug effectiveness (controlled BP, absent side effects).</li>
                        <li>Evaluate patient adherence to medication schedule.</li>
                        <li>Evaluate patient knowledge of medication.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: NP - Alpha Blockers</h4>
                <ul>
                    <li><strong>Assess:</strong> Med history (protein binding!), baseline VS/weight, UO (contraindicated in renal disease).</li>
                    <li><strong>Problems:</strong> HTN, fatigue, orthostatic hypotension, edema, sexual dysfunction.</li>
                    <li><strong>Goals:</strong> BP &le;120/80, proper regimen adherence.</li>
                    <li><strong>Intervene:</strong> Monitor VS (full effect up to 4wks), check for fluid retention/weight gain.</li>
                    <li><strong>Teach:</strong> Adherence (no abrupt stop!). Orthostatic hypotension (rise slowly, take at bedtime). Daily weights. Self-monitor BP. Report dizziness/impotence/edema. Avoid OTC cold meds. Decrease salt.</li>
                    <li><strong>Evaluate:</strong> BP control, compliance, knowledge.</li>
                </ul>
            </div>
        </section>

        <section id="vasodilators">
            <h2>13. Direct-Acting Arteriolar Vasodilators: Opening the Vessels</h2>
            <div class="info-card">
                <p><span class="tooltip-container">Direct-Acting Arteriolar Vasodilators<span class="tooltip-text">Potent antihypertensive drugs that relax the smooth muscles of the blood vessels, primarily arteries, causing vasodilation. Used for moderate to severe hypertension and hypertensive emergencies.</span></span> are potent antihypertensive drugs that relax the smooth muscles of blood vessels, mainly arteries, causing vasodilation.</p>
                <h4>Key Effects:</h4>
                <ul>
                    <li>Increase blood flow to the brain and kidneys.</li>
                    <li>Decrease BP.</li>
                    <li>Can cause sodium and water retention (peripheral edema); often given with diuretics.</li>
                    <li>Cause less orthostatic hypotension compared to other classes due to minimal dilation of arterioles.</li>
                </ul>
                <p>Examples: Hydralazine and Minoxidil (for moderate to severe hypertension). Nitroprusside (for acute hypertensive emergencies).</p>
                <div class="note">
                    <p>Reflex tachycardia and renin release can occur due to vasodilation and decreased BP. Beta blockers are often prescribed concurrently to decrease heart rate and counteract reflex tachycardia.</p>
                </div>
                <button class="reveal-button">Side Effects and Adverse Reactions</button>
                <div class="reveal-content">
                    <ul>
                        <li><strong>Hydralazine:</strong> Reflex tachycardia, palpitations, edema, nasal congestion, headache, dizziness, lupus-like symptoms, neurologic symptoms (tingling, numbness).</li>
                        <li><strong>Minoxidil:</strong> Similar side effects, plus excess hair growth, can precipitate an anginal attack.</li>
                        <li><strong>Nitroprusside:</strong> Reflex tachycardia, palpitations, restlessness, agitation, nausea, confusion.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Direct Vasodilators</h4>
                <ul>
                    <li>Relax arterial smooth muscle, cause vasodilation.</li>
                    <li>Increase blood flow to brain/kidneys, decrease BP.</li>
                    <li>Cause fluid retention (give with diuretics).</li>
                    <li>Less orthostatic hypotension.</li>
                    <li>Cause reflex tachycardia (give with beta blockers).</li>
                    <li>Examples: Hydralazine, Minoxidil, Nitroprusside (emergency).</li>
                </ul>
            </div>
        </section>

        <section id="ace-inhibitors">
            <h2>14. Angiotensin-Converting Enzyme (ACE) Inhibitors: Blocking the RAAS</h2>
            <div class="info-card">
                <p><span class="tooltip-container">ACE Inhibitors<span class="tooltip-text">Drugs that inhibit the angiotensin-converting enzyme, which prevents the formation of angiotensin II (a potent vasoconstrictor) and blocks the release of aldosterone. This leads to vasodilation and decreased fluid retention.</span></span> inhibit ACE, preventing the formation of angiotensin II (a potent vasoconstrictor) and blocking aldosterone release (which normally promotes sodium retention and potassium excretion). This leads to:</p>
                <ul>
                    <li>Sodium excretion with water.</li>
                    <li>Potassium retention.</li>
                    <li>Little change in cardiac output or heart rate.</li>
                    <li>Lowered peripheral resistance.</li>
                </ul>
                <div class="note">
                    <p>ACE inhibitors are used primarily for hypertension and heart failure. They are first-line antihypertensive therapy, though JNC 8 recommends thiazide diuretics first.</p>
                </div>
                <p>Examples: Benazepril, Captopril, Enalapril, Lisinopril, Ramipril, etc.</p>
                <div class="patient-safety">
                    <h4>Contraindications!</h4>
                    <ul>
                        <li><strong>Pregnancy:</strong> Do NOT give during pregnancy (can harm fetus by reducing placental blood flow).</li>
                        <li><strong>Potassium-Sparing Diuretics/Salt Substitutes:</strong> Do NOT take with these (risk of severe <span class="highlight">hyperkalemia</span>).</li>
                    </ul>
                </div>
                <div class="note">
                    <p>African Americans and older adults may not respond as well to ACE inhibitors alone; often require a diuretic for effective BP reduction.</p>
                </div>
                <button class="reveal-button">Side Effects and Adverse Reactions</button>
                <div class="reveal-content">
                    <ul>
                        <li>Primary side effect: A constant, irritated, <span class="highlight">nonproductive cough</span> (may resolve upon discontinuation; ARB may be substituted).</li>
                        <li>Nausea, vomiting, diarrhea, headache, dizziness, fatigue, insomnia, tachycardia.</li>
                        <li><span class="highlight">Hyperkalemia</span> (serum potassium excess).</li>
                        <li>Major adverse effect: <span class="highlight">First-dose hypotension</span> (more common in patients taking diuretics).</li>
                        <li><span class="highlight">Angioedema</span> (swelling of face, tongue, lips, larynx, extremities): Rare but serious hypersensitivity reaction, higher incidence in African Americans. Requires immediate discontinuation and sometimes epinephrine.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: ACE Inhibitors</h4>
                <ul>
                    <li>Block Angiotensin II formation & Aldosterone release.</li>
                    <li>Result: Na+/H2O excretion, K+ retention, vasodilation, decreased peripheral resistance.</li>
                    <li>Uses: HTN, HF.</li>
                    <li>Side effects: Persistent cough, hyperkalemia, first-dose hypotension, angioedema (rare, serious, higher in African Americans).</li>
                    <li>Contraindicated in pregnancy, and with K+-sparing diuretics/K+ salt substitutes.</li>
                    <li>Less effective alone in African Americans/older adults (combine with diuretic).</li>
                </ul>
            </div>
        </section>

        <section id="np-ace-inhibitors">
            <h2>15. Clinical Judgment: Nursing Process - Antihypertensives: ACE Inhibitors</h2>
            <div class="info-card">
                <p>Our core concept here is: <span class="highlight">Perfusion</span>.</p>
                <button class="reveal-button">Your Nursing Superpowers: Assessment to Evaluation!</button>
                <div class="reveal-content">
                    <h3>Recognize Cues [Assessment]: What do you notice?</h3>
                    <ul>
                        <li><strong>Drug and Herbal History:</strong> Obtain a complete history. Report potential interactions.</li>
                        <li><strong>Baseline Vital Signs:</strong> Obtain for future comparisons.</li>
                        <li><strong>Laboratory Values:</strong> Check serum protein, albumin, BUN, creatinine, potassium, and WBC count for baseline.</li>
                    </ul>

                    <h3>Analyze Cues and Prioritize Hypothesis [Patient Problems]: What's the biggest issue?</h3>
                    <ul>
                        <li>Hypertension</li>
                        <li>Anxiety</li>
                        <li>Fatigue</li>
                        <li>Risk for hyperkalemia</li>
                        <li>Risk for first-dose hypotension</li>
                        <li>Risk for angioedema</li>
                    </ul>

                    <h3>Generate Outcomes [Planning]: What's the goal?</h3>
                    <ul>
                        <li>Patient’s blood pressure (BP) will decrease to 120/80 or below.</li>
                        <li>Patient will rise to an upright position slowly to avoid orthostatic hypotension.</li>
                    </ul>

                    <h3>Take Action [Nursing Interventions]: What do YOU do?</h3>
                    <ul>
                        <li><strong>Monitor BP:</strong> Report a sudden drop in BP.</li>
                        <li><strong>Monitor Laboratory Tests:</strong> Renal function (BUN, creatinine, protein), blood glucose levels. Caution: Watch for hypoglycemic reactions in diabetic patients (ACEIs can potentiate insulin).</li>
                        <li><strong>Bleeding Signs:</strong> Report any bruising, petechiae, or bleeding (may indicate severe adverse reaction like thrombocytopenia, especially with captopril).</li>
                    </ul>

                    <h3>Patient Teaching: Empowering Your Patient!</h3>
                    <h4>General:</h4>
                    <ul>
                        <li><strong>Discontinuation:</strong> Warn patients NOT to abruptly discontinue (rebound hypertension possible).</li>
                        <li><strong>OTC Drugs:</strong> Inform patients not to take OTC drugs (e.g., cold medications) without consulting a provider.</li>
                        <li><strong>Salt Substitutes:</strong> Advise patients NOT to use salt substitutes containing potassium (risk of hyperkalemia).</li>
                        <li><strong>Pregnancy:</strong> Warn pregnant patients or those contemplating pregnancy NOT to take ACE inhibitors or ARBs (harm to fetus).</li>
                        <li><strong>Orthostatic Hypotension:</strong> Teach patients to rise slowly.</li>
                    </ul>
                    <h4>Self-Administration:</h4>
                    <ul>
                        <li>Teach patients/family how to take and record BP. Establish a chart and report changes.</li>
                    </ul>
                    <h4>Side Effects:</h4>
                    <ul>
                        <li><strong>Dizziness/Lightheadedness:</strong> Explain it may occur during the first week of therapy; notify provider if it persists.</li>
                        <li><strong>Monitor for:</strong> Angioedema (swelling of face/lips/tongue), cough, dysgeusia (taste disturbance), weakness, hyperkalemia, orthostatic hypotension, renal impairment.</li>
                        <li><strong>Bleeding:</strong> Advise patients to report any occurrence of bleeding.</li>
                    </ul>
                    <h4>Diet:</h4>
                    <ul>
                        <li><strong>Captopril Timing:</strong> Teach to take captopril 20 minutes to 1 hour before a meal (food decreases absorption).</li>
                        <li><strong>Taste Disturbance:</strong> Warn that taste of food may be diminished during first month of therapy.</li>
                        <li><strong>High Potassium Foods:</strong> Advise patients to avoid foods high in potassium due to hyperkalemia risk.</li>
                    </ul>

                    <h3>Evaluate Outcomes [Evaluation]: Did it work?</h3>
                    <ul>
                        <li>Evaluate effectiveness (absence of severe side effects, BP returns to desired range).</li>
                        <li>Evaluate patient’s renal function.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: NP - ACE Inhibitors</h4>
                <ul>
                    <li><strong>Assess:</strong> Drug/herb history, baseline VS, labs (protein, albumin, BUN, creatinine, K+, WBC).</li>
                    <li><strong>Problems:</strong> HTN, anxiety, fatigue, hyperkalemia risk, hypotension risk, angioedema risk.</li>
                    <li><strong>Goals:</strong> BP &le;120/80, slow position changes.</li>
                    <li><strong>Intervene:</strong> Monitor BP, renal labs, bleeding signs.</li>
                    <li><strong>Teach:</strong> No abrupt stop, avoid OTCs/K+ salt substitutes. Pregnancy warning. Rise slowly. Self-monitor BP. Report dizziness/angioedema/cough/bleeding. Captopril on empty stomach. Taste changes. Avoid high K+ foods.</li>
                    <li><strong>Evaluate:</strong> BP control, side effect absence, renal function.</li>
                </ul>
            </div>
        </section>

        <section id="arbs">
            <h2>16. Angiotensin II–Receptor Blockers (ARBs): Alternative to ACEIs</h2>
            <div class="info-card">
                <p><span class="tooltip-container">Angiotensin II–Receptor Blockers (ARBs)<span class="tooltip-text">Drugs that block angiotensin II from binding to angiotensin I (AT1) receptors in tissues, causing vasodilation and decreased peripheral resistance. Used for hypertension and heart failure, particularly in patients who cannot tolerate ACE inhibitors.</span></span> are similar to ACE inhibitors in that they prevent aldosterone release and act on the RAAS. However, ARBs directly block angiotensin II from binding to angiotensin I (AT1) receptors in many tissues.</p>
                <h4>Key Differences from ACEIs:</h4>
                <ul>
                    <li>Cause vasodilation and decrease peripheral resistance.</li>
                    <li>DO NOT cause the constant, irritated cough often seen with ACE inhibitors.</li>
                </ul>
                <p>Examples: Losartan, Valsartan, Irbesartan, Candesartan, Olmesartan, etc.</p>
                <div class="note">
                    <p>Like ACE inhibitors, ARBs should NOT be taken during pregnancy. They are also less effective for treating hypertension in African American patients unless combined with a diuretic.</p>
                </div>
                <p>ARBs may be used as a first-line treatment for hypertension. They can be taken with or without food and are suitable for patients with mild hepatic insufficiency.</p>
                <table class="prototype-drug-chart responsive-table">
                    <thead>
                        <tr>
                            <th>Drug Class</th>
                            <th>Dosage</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td data-label="Drug Class">Antihypertensive: Angiotensin II–receptor blocker</td>
                            <td data-label="Dosage">
                                Hypertension:<br>
                                A: PO: Initially 80–160 mg/d; maint: 80–320 mg/d; max: 320 mg/d
                            </td>
                        </tr>
                        <tr>
                            <th colspan="2">Watch Out For! (Contraindications & Interactions)</th>
                        </tr>
                        <tr>
                            <td data-label="Contraindications" colspan="2">
                                Hypersensitivity<br>
                                <strong>Caution:</strong> Renal and hepatic impairments, hypotension, heart failure, hypovolemia, hyperkalemia, older adults, Blacks, pregnancy, breastfeeding
                            </td>
                        </tr>
                        <tr>
                            <td data-label="Drug-Lab-Food Interactions" colspan="2">
                                <strong>Antihypertensives, diuretics, MAOIs, and alcohol:</strong> may increase hypotensive effects;<br>
                                <strong>ACE inhibitors and aspirin:</strong> may increase hyperkalemia and renal dysfunction;<br>
                                <strong>Digoxin and NSAIDs:</strong> may increase renal dysfunction;<br>
                                <strong>Lithium:</strong> may increase lithium toxicity.<br>
                                <strong>Lab:</strong> May increase AST, ALT, ALP, bilirubin, BUN, creatinine, Hct, Hgb
                            </td>
                        </tr>
                        <tr>
                            <th>How it Moves (Pharmacokinetics)</th>
                            <th>How it Works (Pharmacodynamics)</th>
                        </tr>
                        <tr>
                            <td data-label="Pharmacokinetics">
                                <strong>Absorption:</strong> Rapidly absorbed, 10%–35% in blood circulation<br>
                                <strong>Distribution:</strong> PB: 95%<br>
                                <strong>Metabolism:</strong> t½: 6 h<br>
                                <strong>Excretion:</strong> 13% in urine and 83% in bile/feces
                            </td>
                            <td data-label="Pharmacodynamics">
                                <strong>PO:</strong> Onset: 2 h; Peak: 6 h; Duration: 24 h<br>
                                <strong>Therapeutic Effects/Uses:</strong> To treat hypertension and heart failure<br>
                                <strong>Mechanism of Action:</strong> Potent vasodilator that inhibits binding of angiotensin II.
                            </td>
                        </tr>
                        <tr>
                            <th>Side Effects</th>
                            <th>Adverse Reactions</th>
                        </tr>
                        <tr>
                            <td data-label="Side Effects">Dizziness, drowsiness, cough, palpitations, blurred vision, headache, edema, nausea, diarrhea, abdominal and back pain, arthralgia, fatigue, muscle cramps, pharyngitis, erectile dysfunction</td>
                            <td data-label="Adverse Reactions">Orthostatic hypotension, chest pain, hyperkalemia, rhabdomyolysis, elevated hepatic enzymes<br>
                                <strong>Life-threatening:</strong> Renal dysfunction, neutropenia
                            </td>
                        </tr>
                    </tbody>
                </table>
                <div class="patient-safety">
                    <h4>Do Not Confuse!</h4>
                    <p><strong>Diovan (valsartan)</strong>, an angiotensin II–receptor blocker, and <strong>Dioval (estradiol)</strong>, an estrogen hormone. Caution must be taken to select the correct drug.</p>
                </div>
                <p>ARBs also carry a risk of angioedema, similar to ACE inhibitors.</p>
            </div>
            <div class="recap">
                <h4>Recap: ARBs</h4>
                <ul>
                    <li>Block Angiotensin II from binding to AT1 receptors.</li>
                    <li>Cause vasodilation, decrease peripheral resistance.</li>
                    <li>NO cough (unlike ACEIs).</li>
                    <li>Uses: HTN, HF.</li>
                    <li>Side effects: Dizziness, hypotension, hyperkalemia, angioedema (rare).</li>
                    <li>Contraindicated in pregnancy. Less effective alone in African Americans.</li>
                </ul>
            </div>
        </section>

        <section id="direct-renin-inhibitors">
            <h2>17. Direct Renin Inhibitors: A New Approach</h2>
            <div class="info-card">
                <p>The first FDA-approved direct renin inhibitor for treating hypertension is <span class="highlight">Aliskiren</span>. It works by directly binding with renin, which leads to a reduction of angiotensin I, angiotensin II, and aldosterone levels.</p>
                <ul>
                    <li>Effective for mild and moderate hypertension.</li>
                    <li>Can be used alone or with other antihypertensive agents.</li>
                    <li>Has an additive effect when combined with a thiazide diuretic or an ARB.</li>
                </ul>
                <div class="note">
                    <p>When used as monotherapy, Aliskiren has not proven to be as effective in reducing BP in the African American population.</p>
                </div>
                <button class="reveal-button">Aliskiren Side Effects</button>
                <div class="reveal-content">
                    <ul>
                        <li>Dizziness, hypotension, hyperkalemia.</li>
                        <li>Peripheral edema, diarrhea, hyperuricemia, gout, pharyngitis, cough.</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Direct Renin Inhibitors</h4>
                <ul>
                    <li>Aliskiren: Directly binds renin, reduces Angiotensin I/II/Aldosterone.</li>
                    <li>Uses: Mild/moderate HTN (alone or combo).</li>
                    <li>Less effective alone in African Americans.</li>
                    <li>Side effects: Dizziness, hypotension, hyperkalemia.</li>
                </ul>
            </div>
        </section>

        <section id="calcium-channel-blockers">
            <h2>18. Calcium Channel Blockers (CCBs): Inhibiting Calcium Influx</h2>
            <div class="info-card">
                <p>Slow calcium channels are found in the myocardium and vascular smooth muscle (VSM) cells. Free calcium increases muscle contractility, peripheral resistance, and BP.</p>
                <p><span class="tooltip-container">Calcium Channel Blockers (CCBs)<span class="tooltip-text">Also called calcium antagonists. These drugs block calcium channels in vascular smooth muscle, promoting vasodilation and decreasing myocardial contractility. Used for hypertension, angina, and dysrhythmias.</span></span> block the calcium channels in VSM, promoting <span class="highlight">vasodilation</span>.</p>
                <h4>Key Effects:</h4>
                <ul>
                    <li>Promote vasodilation (especially in coronary and cerebral arteries and peripheral vessels).</li>
                    <li>Decrease myocardial contractility.</li>
                    <li>Lower peripheral resistance and BP.</li>
                </ul>
                <p>CCBs are highly protein bound but often have short half-lives (slow-release preparations decrease administration frequency).</p>
                <h3>Groups of CCBs:</h3>
                <ul>
                    <li><strong>Phenylalkylamines (e.g., Verapamil):</strong> Act on arterioles and heart. Used for chronic HTN, angina, cardiac dysrhythmias.</li>
                    <li><strong>Benzothiazepines (e.g., Diltiazem):</strong> Act on arterioles and heart. Used for HTN, angina, cardiac dysrhythmias.</li>
                    <li><strong>Dihydropyridines (e.g., Amlodipine, Nifedipine):</strong> Largest group, primarily for hypertension.</li>
                </ul>
                <div class="patient-safety">
                    <h4>Nifedipine Warning!</h4>
                    <p>Immediate-release Nifedipine (10- and 20-mg capsules) is associated with increased incidence of profound hypotension, MI, and death, especially in older adults. ONLY <span class="highlight">extended-release preparations</span> are recommended for chronic hypertension. Immediate-release Nifedipine is typically reserved for acute BP rises in the hospital setting, as needed.</p>
                </div>
                <div class="note">
                    <p>CCBs lower BP better in African Americans than do drugs in other categories.</p>
                    <p>CCBs can cause reflex tachycardia, especially nifedipine. Beta blockers are generally not prescribed with CCBs because both decrease myocardial contractility, leading to excessive bradycardia or AV block.</p>
                </div>
                <table class="prototype-drug-chart responsive-table">
                    <thead>
                        <tr>
                            <th>Drug Class</th>
                            <th>Dosage</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td data-label="Drug Class">Antihypertensive: Calcium channel blocker</td>
                            <td data-label="Dosage">
                                Hypertension:<br>
                                A: PO: Initially 5 mg/d; maint: 5–10 mg/d; max: 10 mg/d<br>
                                Older A: PO: 2.5 mg/d; maint: 2.5–10 mg/d; max: 10 mg/d
                            </td>
                        </tr>
                        <tr>
                            <th colspan="2">Watch Out For! (Contraindications & Interactions)</th>
                        </tr>
                        <tr>
                            <td data-label="Contraindications" colspan="2">
                                Hypersensitivity<br>
                                <strong>Caution:</strong> Hepatic impairment, acute MI, coronary artery disease, older adults, pregnancy, breastfeeding
                            </td>
                        </tr>
                        <tr>
                            <td data-label="Drug-Lab-Food Interactions" colspan="2">
                                <strong>Antihypertensives:</strong> may increase hypotensive effects; <strong>NSAIDs:</strong> may increase renal dysfunction; <strong>hydrocodone and codeine:</strong> may increase sedation; <strong>pseudoephedrine and phenylephrine:</strong> decrease antihypertensive effects.
                            </td>
                        </tr>
                        <tr>
                            <th>How it Moves (Pharmacokinetics)</th>
                            <th>How it Works (Pharmacodynamics)</th>
                        </tr>
                        <tr>
                            <td data-label="Pharmacokinetics">
                                <strong>Absorption:</strong> Well absorbed<br>
                                <strong>Distribution:</strong> PB: 93%<br>
                                <strong>Metabolism:</strong> t½: 30–50 h<br>
                                <strong>Excretion:</strong> Excreted in urine
                            </td>
                            <td data-label="Pharmacodynamics">
                                <strong>PO:</strong> Onset: UK; Peak: 6–12 h; Duration: 24 h<br>
                                <strong>Therapeutic Effects/Uses:</strong> To treat hypertension and coronary artery disease.<br>
                                <strong>Mechanism of Action:</strong> Inhibits influx of extracellular calcium across myocardial and vascular smooth muscle cell membranes, resulting in decreased myocardial contractility.
                            </td>
                        </tr>
                        <tr>
                            <th>Side Effects</th>
                            <th>Adverse Reactions</th>
                        </tr>
                        <tr>
                            <td data-label="Side Effects">Dizziness, drowsiness, anxiety, flushing, fatigue, weakness, syncope, peripheral edema, depression, visual impairment, paresthesia, diaphoresis, arthralgia, myalgia, muscle cramps, nausea, anorexia, abdominal pain, vomiting, diarrhea, constipation, nightmares, insomnia, weight loss/gain, rash, pruritus, erectile dysfunction</td>
                            <td data-label="Adverse Reactions">Orthostatic hypotension, bradycardia, chest pain, tachycardia, palpitations, dyspnea, hyperglycemia<br>
                                <strong>Life-threatening:</strong> Angioedema, dysrhythmia exacerbation, MI, thrombocytopenia
                            </td>
                        </tr>
                    </tbody>
                </table>
                <button class="reveal-button">Side Effects and Adverse Reactions</button>
                <div class="reveal-content">
                    <ul>
                        <li>Flushing, headache, dizziness, ankle edema (peripheral edema).</li>
                        <li>Bradycardia, AV block.</li>
                        <li>Can cause reflex tachycardia (more prevalent with nifedipine).</li>
                        <li>Can cause angioedema (rare, but life-threatening).</li>
                    </ul>
                </div>
            </div>
            <div class="recap">
                <h4>Recap: Calcium Channel Blockers</h4>
                <ul>
                    <li>Block calcium channels in VSM, cause vasodilation.</li>
                    <li>Decrease contractility, peripheral resistance, BP.</li>
                    <li>Uses: HTN, angina, dysrhythmias.</li>
                    <li>Effective in African Americans.</li>
                    <li>Nifedipine IR form: dangerous, use ER for chronic HTN.</li>
                    <li>Side effects: Flushing, headache, dizziness, ankle edema, bradycardia, reflex tachycardia, angioedema.</li>
                    <li>Generally avoid with beta blockers.</li>
                </ul>
            </div>
        </section>

        <section id="critical-thinking" class="nclex-next-gen">
            <h3>19. NCLEX Next Gen! Critical Thinking Case Study</h3>
            <p class="case-study">A 72-year-old African American patient has heart failure and diabetes. Her vital signs are blood pressure 176/94, pulse 92, and respirations 30. Her medications include hydrochlorothiazide 50 mg/day, digoxin 0.125 mg/day, and atenolol 50 mg/day.</p>

            <div class="fill-in-the-blank">
                <h4>Question 1: Why was hydrochlorothiazide prescribed for this patient? Explain the effects of hydrochlorothiazide on blood pressure.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 2: Abnormal electrolytes and other laboratory test results may occur when taking hydrochlorothiazide. Would the following serum electrolyte and laboratory values be expected to increase or decrease?</h4>
                <ul>
                    <li>a. Sodium: <input type="radio" name="cs_q2_a" value="increase"> Increase <input type="radio" name="cs_q2_a" value="decrease"> Decrease</li>
                    <li>b. Potassium: <input type="radio" name="cs_q2_b" value="increase"> Increase <input type="radio" name="cs_q2_b" value="decrease"> Decrease</li>
                    <li>c. Calcium: <input type="radio" name="cs_q2_c" value="increase"> Increase <input type="radio" name="cs_q2_c" value="decrease"> Decrease</li>
                    <li>d. Magnesium: <input type="radio" name="cs_q2_d" value="increase"> Increase <input type="radio" name="cs_q2_d" value="decrease"> Decrease</li>
                    <li>e. Glucose: <input type="radio" name="cs_q2_e" value="increase"> Increase <input type="radio" name="cs_q2_e" value="decrease"> Decrease</li>
                    <li>f. Uric acid: <input type="radio" name="cs_q2_f" value="increase"> Increase <input type="radio" name="cs_q2_f" value="decrease"> Decrease</li>
                </ul>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 3: Why should this patient’s blood glucose level be monitored while she is taking hydrochlorothiazide?</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 4: What response does a health care provider need to keep in mind when prescribing antihypertensive agents (specifically for African American patients)? Explain your answer.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 5: Atenolol is what type of antihypertensive? Would atenolol be effective in lowering this patient’s blood pressure if given as the only antihypertensive drug? Explain your answer.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 6: How effective is the combination of hydrochlorothiazide and atenolol for controlling this patient’s blood pressure? Explain your answer.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 7: When using a combination drug therapy to correct hypertension, would the dosage for each drug be the same? Explain your answer.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 8: When abruptly discontinuing beta blockers for hypertension without the patient taking another antihypertensive, what might occur? Explain how adverse effects can be avoided.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <p class="case-study">This patient’s blood glucose is 229. Her drugs for controlling hypertension are changed to prazosin 10 mg three times daily. Her cholesterol and LDL are elevated, and her serum potassium level is 3.2 mEq/L.</p>

            <div class="fill-in-the-blank">
                <h4>Question 9: Why were this patient’s hydrochlorothiazide and atenolol discontinued? Explain your answer.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 10: What type of antihypertensive is prazosin? Explain the physiologic action of prazosin for lowering the blood pressure.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 11: Does prazosin have an effect on the blood glucose level? What effect could prazosin have on this patient’s abnormal lipid levels? Explain your answer.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <p class="case-study">This patient’s ankles have become edematous. Hydrochlorothiazide is again prescribed.</p>

            <div class="fill-in-the-blank">
                <h4>Question 12: Why was hydrochlorothiazide again added to the drug regimen?</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 13: Is the daily prazosin dose within the safe therapeutic prescribed range for this patient? Explain your answer. (You may refer to Prototype Drug Chart: Prazosin Hydrochloride.)</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <div class="fill-in-the-blank">
                <h4>Question 14: List the groups of antihypertensive drugs that can cause sodium and water retention.</h4>
                <textarea rows="5" placeholder="Type your answer here..."></textarea>
            </div>

            <button class="submit-btn" id="submit_case_study">Reveal Rationale!</button>
            <div class="feedback" id="case_study_feedback"></div>
            <div class="rationale" id="case_study_rationale">
                <h4>Rationale for Critical Thinking Case Study</h4>
                <h5>Question 1: Why was hydrochlorothiazide prescribed for this patient? Explain the effects of hydrochlorothiazide on blood pressure.</h5>
                <p>Hydrochlorothiazide (HCTZ) is a thiazide diuretic, which is often a first-line drug for treating mild to moderate hypertension. It was likely prescribed for this patient to help lower her elevated blood pressure (176/94) and manage her heart failure by reducing fluid volume, which would also help with any associated edema. HCTZ works by acting on the renal distal tubules, promoting the excretion of sodium, chloride, and water. This leads to a decrease in vascular fluid volume and a concomitant decrease in cardiac output and blood pressure. It also acts on arterioles, causing vasodilation, which directly lowers blood pressure.</p>

                <h5>Question 2: Abnormal electrolytes and other laboratory test results may occur when taking hydrochlorothiazide. Would the following serum electrolyte and laboratory values be expected to increase or decrease?</h5>
                <ul>
                    <li>a. Sodium: **Decrease** (Thiazides promote sodium excretion.)</li>
                    <li>b. Potassium: **Decrease** (Thiazides are potassium-wasting diuretics.)</li>
                    <li>c. Calcium: **Increase** (Thiazides promote calcium reabsorption.)</li>
                    <li>d. Magnesium: **Decrease** (Thiazides cause magnesium loss.)</li>
                    <li>e. Glucose: **Increase** (Thiazides can cause hyperglycemia.)</li>
                    <li>f. Uric acid: **Increase** (Thiazides can block uric acid excretion, leading to hyperuricemia.)</li>
                </ul>

                <h5>Question 3: Why should this patient’s blood glucose level be monitored while she is taking hydrochlorothiazide?</h5>
                <p>The patient has diabetes. Hydrochlorothiazide (a thiazide diuretic) can affect glucose tolerance and may cause hyperglycemia (elevated blood glucose levels). This is especially true in patients who are already diabetic or prediabetic. Therefore, regular monitoring of her blood glucose is essential to ensure her diabetes remains controlled and to adjust her antidiabetic medication if necessary.</p>

                <h5>Question 4: What response does a health care provider need to keep in mind when prescribing antihypertensive agents (specifically for African American patients)? Explain your answer.</h5>
                <p>When prescribing antihypertensive agents for African American patients, a healthcare provider needs to be aware that certain drug classes, specifically beta-adrenergic blockers (beta blockers) and Angiotensin-Converting Enzyme (ACE) inhibitors, are generally less effective for hypertension control in this population when used as monotherapy. African American patients are more susceptible to "low-renin hypertension," which means these drugs, which primarily work by impacting the renin-angiotensin system, may not be as efficacious. Instead, African American patients tend to respond well to alpha1 blockers, calcium channel blockers (CCBs), and diuretics as initial monotherapy or in combination with other agents.</p>

                <h5>Question 5: Atenolol is what type of antihypertensive? Would atenolol be effective in lowering this patient’s blood pressure if given as the only antihypertensive drug? Explain your answer.</h5>
                <p>Atenolol is a **cardioselective beta1 blocker**. It works by blocking beta1-adrenergic receptors, primarily in the heart, leading to a decrease in heart rate, myocardial contractility, and blood pressure. However, given that this patient is African American, atenolol would likely **NOT be effective in lowering her blood pressure if given as the only antihypertensive drug.** As discussed in Cultural Responses, beta blockers are generally less effective as monotherapy for African American patients due to their predisposition to low-renin hypertension. Atenolol would typically need to be combined with a diuretic for optimal BP control in this patient.</p>

                <h5>Question 6: How effective is the combination of hydrochlorothiazide and atenolol for controlling this patient’s blood pressure? Explain your answer.</h5>
                <p>The combination of hydrochlorothiazide (a thiazide diuretic) and atenolol (a beta blocker) is generally **more effective** for controlling blood pressure in an African American patient than atenolol alone. Hydrochlorothiazide, as a diuretic, is a first-line agent and is effective in African American patients. When combined with a beta blocker like atenolol, the diuretic helps to reduce fluid volume and addresses the responsiveness issues of beta blockers in low-renin hypertension common in this population. This combination can lead to a more significant reduction in blood pressure than either drug used as monotherapy in this specific patient.</p>

                <h5>Question 7: When using a combination drug therapy to correct hypertension, would the dosage for each drug be the same? Explain your answer.</h5>
                <p>No, when using combination drug therapy, the dosage for each drug would **not necessarily be the same**. Dosages are typically individualized based on the patient's specific needs, response to the medications, presence of comorbidities (like heart failure and diabetes in this case), and potential side effects. The goal is to use the lowest effective dose of each component to achieve target blood pressure while minimizing adverse effects. Often, combination products come with fixed low doses of each component, but individual titration of each drug may be done before or during the use of a fixed-dose combination.</p>

                <h5>Question 8: When abruptly discontinuing beta blockers for hypertension without the patient taking another antihypertensive, what might occur? Explain how adverse effects can be avoided.</h5>
                <p>When beta blockers are abruptly discontinued for hypertension, especially without another antihypertensive in place, the patient can experience a **rebound hypertensive crisis**. This is due to the sudden removal of beta blockade, leading to an exaggerated sympathetic nervous system response. Symptoms can include severe hypertension, tachycardia, angina, dysrhythmias, and even myocardial infarction. These adverse effects can be avoided by **tapering the beta blocker dose down gradually** over a specified period (e.g., 1 to 2 weeks), allowing the body's cardiovascular system to adjust. If the beta blocker must be stopped immediately, another appropriate antihypertensive drug should be prescribed concurrently to mitigate the rebound effect.</p>

                <h5>Question 9: Why were this patient’s hydrochlorothiazide and atenolol discontinued? Explain your answer.</h5>
                <p>The patient's hydrochlorothiazide (HCTZ) and atenolol were likely discontinued for several reasons based on her new presentation:</p>
                <ul>
                    <li><strong>Elevated Blood Glucose (229):</strong> HCTZ (a thiazide diuretic) is known to cause hyperglycemia, which would worsen her pre-existing diabetes. Atenolol (a beta blocker) can also mask symptoms of hypoglycemia and may worsen glucose control in some diabetic patients.</li>
                    <li><strong>Elevated Cholesterol and LDL:</strong> Thiazide diuretics (HCTZ) can cause hyperlipidemia (elevated cholesterol, LDL, and triglycerides). Beta blockers can also have varying effects on lipids, sometimes increasing triglycerides and decreasing HDL.</li>
                    <li><strong>Serum Potassium 3.2 mEq/L (Hypokalemia):</strong> HCTZ is a potassium-wasting diuretic, and her low potassium level (normal is 3.5-5.0 mEq/L) indicates that it was contributing to this electrolyte imbalance. This is particularly concerning as hypokalemia can increase the risk of digoxin toxicity (she is on digoxin).</li>
                    <li><strong>Inadequate BP Control:</strong> Despite being on these drugs, her BP was still significantly elevated at 176/94, indicating that the current regimen was not sufficiently controlling her hypertension, especially given the racial considerations for beta blockers.</li>
                </ul>
                <p>The combination of these side effects and inadequate BP control necessitates a change in therapy.</p>

                <h5>Question 10: What type of antihypertensive is prazosin? Explain the physiologic action of prazosin for lowering the blood pressure.</h5>
                <p>Prazosin is a **selective alpha1-adrenergic blocker (alpha blocker)**. Its physiologic action involves blocking the alpha1-adrenergic receptors located on the smooth muscle of peripheral blood vessels (both arterioles and venules). This blockade prevents the vasoconstrictive effects of norepinephrine, leading to relaxation and dilation of these blood vessels. The resulting vasodilation decreases peripheral vascular resistance, which directly lowers blood pressure. Prazosin causes only a slight increase in heart rate, making it a good option for BP control.</p>

                <h5>Question 11: Does prazosin have an effect on the blood glucose level? What effect could prazosin have on this patient’s abnormal lipid levels? Explain your answer.</h5>
                <ul>
                    <li><strong>Blood Glucose:</strong> Prazosin, as an alpha-adrenergic blocker, generally **does not affect glucose metabolism**, making it a safer option for diabetic patients compared to thiazides or some beta blockers that can worsen hyperglycemia or mask hypoglycemia.</li>
                    <li><strong>Lipid Levels:</strong> Prazosin can have a **beneficial effect on abnormal lipid levels**. Alpha blockers are known to decrease very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol, which are "bad" cholesterols contributing to fatty plaque buildup (atherosclerosis). They also tend to increase high-density lipoprotein (HDL) levels, which is "good" cholesterol. This would be advantageous for a patient with elevated cholesterol and LDL, like this one.</li>
                </ul>

                <h5>Question 12: Why was hydrochlorothiazide again added to the drug regimen?</h5>
                <p>Hydrochlorothiazide was likely added back to the drug regimen because the patient developed **edema** in her ankles. While prazosin is effective for hypertension and beneficial for lipids and glucose, it can cause sodium and water retention, leading to peripheral edema. Adding a diuretic like HCTZ helps to counteract this fluid retention and reduce the edema. Given her history of heart failure, managing fluid overload is crucial, and HCTZ would directly address the edema by promoting fluid excretion.</p>

                <h5>Question 13: Is the daily prazosin dose within the safe therapeutic prescribed range for this patient? Explain your answer. (You may refer to Prototype Drug Chart: Prazosin Hydrochloride.)</h5>
                <p>The patient is prescribed prazosin 10 mg three times daily (tid), which totals 30 mg/day.
                According to the Prototype Drug Chart: Prazosin Hydrochloride:</p>
                <ul>
                    <li>Adult (A) maintenance dose: 6–15 mg/d; max: 20 mg/d in divided doses.</li>
                    <li>Older A: PO: Initially 1 mg qd/bid; max: 20 mg/d.</li>
                </ul>
                <p>Since the patient is 72 years old, she falls into the "Older Adult" category where the maximum recommended dose is 20 mg/d. Her prescribed dose of 30 mg/day is **above the maximum recommended daily dose for an older adult**. While individual patient needs can vary, this dose is typically outside the safe therapeutic prescribed range for an older adult and increases the risk of side effects like orthostatic hypotension.</p>

                <h5>Question 14: List the groups of antihypertensive drugs that can cause sodium and water retention.</h5>
                <p>The groups of antihypertensive drugs that can cause sodium and water retention (leading to peripheral edema) include:</p>
                <ul>
                    <li>**Centrally Acting Alpha2 Agonists** (e.g., clonidine, methyldopa)</li>
                    <li>**Alpha-Adrenergic Blockers** (e.g., prazosin, terazosin, doxazosin)</li>
                    <li>**Adrenergic Neuron Blockers (Peripherally Acting Sympatholytics)** (e.g., reserpine)</li>
                    <li>**Direct-Acting Arteriolar Vasodilators** (e.g., hydralazine, minoxidil)</li>
                    <li>**Calcium Channel Blockers** (e.g., amlodipine, nifedipine – particularly dihydropyridines)</li>
                </ul>
            </div>
            <div class="recap">
                <h4>Recap: Case Study Takeaways</h4>
                <ul>
                    <li>HCTZ (thiazide diuretic) is common for HTN/HF, but causes K+ wasting, hyperglycemia, hyperlipidemia, and hyperuricemia.</li>
                    <li>Atenolol (beta blocker) is less effective alone in African Americans due to low-renin HTN; combination with diuretics improves efficacy.</li>
                    <li>Beta blockers should be tapered slowly upon discontinuation to avoid rebound hypertension.</li>
                    <li>Prazosin (alpha blocker) is good for HTN with lipid abnormalities, doesn't affect glucose, and can help with BPH.</li>
                    <li>Alpha blockers and direct vasodilators can cause fluid retention, often requiring co-administration with diuretics.</li>
                    <li>Always verify drug dosages against recommended guidelines, especially for older adults, to ensure safety.</li>
                </ul>
            </div>
        </section>

        <section id="review-questions">
            <h2>20. Module Review Questions: Test Your Knowledge!</h2>

            <div class="question-card" id="q1">
                <p>1. A patient’s blood pressure is 130/84. The health care provider plans to suggest nonpharmacologic methods to lower blood pressure. Which should the nurse include in teaching? (Select all that apply.)</p>
                <div class="options">
                    <label><input type="checkbox" name="q1_option" value="a"> a. Stress-reduction techniques</label>
                    <label><input type="checkbox" name="q1_option" value="b"> b. An exercise program</label>
                    <label><input type="checkbox" name="q1_option" value="c"> c. Salt restriction</label>
                    <label><input type="checkbox" name="q1_option" value="d"> d. Smoking cessation</label>
                    <label><input type="checkbox" name="q1_option" value="e"> e. A diet with increased protein</label>
                </div>
                <button class="submit-btn" id="submit_q1">Check My Answer!</button>
                <div class="feedback" id="q1_feedback"></div>
            </div>

            <div class="question-card" id="q2">
                <p>2. A patient has developed mild hypertension. The nurse acknowledges that the first-line drug for treating this patient’s blood pressure might be which drug?</p>
                <div class="options">
                    <label><input type="radio" name="q2_option" value="a"> a. Diuretic</label>
                    <label><input type="radio" name="q2_option" value="b"> b. Alpha blocker</label>
                    <label><input type="radio" name="q2_option" value="c"> c. Angiotensin-converting enzyme inhibitor</label>
                    <label><input type="radio" name="q2_option" value="d"> d. Alpha/beta blocker</label>
                </div>
                <button class="submit-btn" id="submit_q2">Check My Answer!</button>
                <div class="feedback" id="q2_feedback"></div>
            </div>

            <div class="question-card" id="q3">
                <p>3. An African American patient has developed hypertension. The nurse is aware that which group(s) of antihypertensive drugs are less effective in African American patients?</p>
                <div class="options">
                    <label><input type="radio" name="q3_option" value="a"> a. Diuretics</label>
                    <label><input type="radio" name="q3_option" value="b"> b. Calcium channel blockers and vasodilators</label>
                    <label><input type="radio" name="q3_option" value="c"> c. Beta blockers and angiotensin-converting enzyme inhibitors</label>
                    <label><input type="radio" name="q3_option" value="d"> d. Alpha blockers</label>
                </div>
                <button class="submit-btn" id="submit_q3">Check My Answer!</button>
                <div class="feedback" id="q3_feedback"></div>
            </div>

            <div class="question-card" id="q4">
                <p>4. The nurse knows that which diuretic is most frequently combined with an antihypertensive drug?</p>
                <div class="options">
                    <label><input type="radio" name="q4_option" value="a"> a. Chlorthalidone</label>
                    <label><input type="radio" name="q4_option" value="b"> b. Hydrochlorothiazide</label>
                    <label><input type="radio" name="q4_option" value="c"> c. Bendroflumethiazide</label>
                    <label><input type="radio" name="q4_option" value="d"> d. A potassium-sparing diuretic</label>
                </div>
                <button class="submit-btn" id="submit_q4">Check My Answer!</button>
                <div class="feedback" id="q4_feedback"></div>
            </div>

            <div class="question-card" id="q5">
                <p>5. The nurse is administering a beta blocker to a patient. Which is the most important assessment to perform before administration?</p>
                <div class="options">
                    <label><input type="radio" name="q5_option" value="a"> a. Urine output</label>
                    <label><input type="radio" name="q5_option" value="b"> b. Apical pulse</label>
                    <label><input type="radio" name="q5_option" value="c"> c. Potassium level</label>
                    <label><input type="radio" name="q5_option" value="d"> d. Serum level of medication</label>
                </div>
                <button class="submit-btn" id="submit_q5">Check My Answer!</button>
                <div class="feedback" id="q5_feedback"></div>
            </div>

            <div class="question-card" id="q6">
                <p>6. Captopril has been prescribed for a patient. The nurse should teach the patient that the most commonly occurring side effect of an angiotensin-converting enzyme drug is which of the following?</p>
                <div class="options">
                    <label><input type="radio" name="q6_option" value="a"> a. Nausea and vomiting</label>
                    <label><input type="radio" name="q6_option" value="b"> b. Dizziness and headaches</label>
                    <label><input type="radio" name="q6_option" value="c"> c. Upset stomach</label>
                    <label><input type="radio" name="q6_option" value="d"> d. Constant, irritating cough</label>
                </div>
                <button class="submit-btn" id="submit_q6">Check My Answer!</button>
                <div class="feedback" id="q6_feedback"></div>
            </div>

            <div class="question-card" id="q7">
                <p>7. A patient is prescribed losartan. The nurse teaches the patient that an angiotensin II-receptor blocker acts by doing what?</p>
                <div class="options">
                    <label><input type="radio" name="q7_option" value="a"> a. Inhibiting angiotensin-converting enzyme</label>
                    <label><input type="radio" name="q7_option" value="b"> b. Blocking angiotensin II from angiotensin I receptors</label>
                    <label><input type="radio" name="q7_option" value="c"> c. Preventing the release of angiotensin I</label>
                    <label><input type="radio" name="q7_option" value="d"> d. Promoting the release of aldosterone</label>
                </div>
                <button class="submit-btn" id="submit_q7">Check My Answer!</button>
                <div class="feedback" id="q7_feedback"></div>
            </div>

            <div class="question-card" id="q8">
                <p>8. During an admission assessment, a patient states that she takes amlodipine. The nurse should inquire about which signs and symptoms to determine whether the patient has any common side effects of amlodipine? (Select all that apply.)</p>
                <div class="options">
                    <label><input type="checkbox" name="q8_option" value="a"> a. Insomnia</label>
                    <label><input type="checkbox" name="q8_option" value="b"> b. Dizziness</label>
                    <label><input type="checkbox" name="q8_option" value="c"> c. Headache</label>
                    <label><input type="checkbox" name="q8_option" value="d"> d. Angioedema</label>
                    <label><input type="checkbox" name="q8_option" value="e"> e. Ankle edema</label>
                    <label><input type="checkbox" name="q8_option" value="f"> f. Hacking cough</label>
                </div>
                <button class="submit-btn" id="submit_q8">Check My Answer!</button>
                <div class="feedback" id="q8_feedback"></div>
            </div>

        </section>
        <section id="drug-mastery-quiz">
            <h2>21. Drug Mastery Challenge: Let's Master These Meds!</h2>
            <p>Ready to test your knowledge on Antihypertensives? Go through each card and see if you can recall the key information!</p>
            <button id="startQuizBtn">Start Drug Mastery Challenge!</button>

            <div class="quiz-card" id="drugQuizCard">
                <div class="progress-tracker">Card <span id="currentCardNum">1</span> of <span id="totalCardsNum">0</span></div>
                <h4 id="drugName">Drug Name Goes Here</h4>
                <p id="drugQuestion">Question about the drug will appear here.</p>

                <div class="quiz-controls">
                    <button id="showAnswerBtn">Show Answer</button>
                </div>

                <div id="answerFeedback">
                    <h5>Answer: <span id="answerType"></span></h5>
                    <p id="answerContent"></p>
                </div>

                <div id="masteryButtons" style="display: none;">
                    <p>Did you get it right?</p>
                    <button id="correctBtn">Yes, I knew it!</button>
                    <button id="incorrectBtn">No, I need to review.</button>
                </div>
            </div>

            <div id="quizSummary">
                <h4>Challenge Complete!</h4>
                <p>You've gone through all the drugs!</p>
                <p>Mastered on first try: <span id="masteredCount">0</span></p>
                <p>Needed review: <span id="missedCount">0</span></p>
                <button id="restartQuizBtn">Restart Full Quiz</button>
                <button id="reviewMissedBtn">Review Missed Drugs</button>
            </div>
        </section>

        <footer>
            <p>&copy; 2025 Antihypertensives Learning Module. Designed for focused learning.</p>
        </footer>
    </div>

    <div id="clockOutOverlay">
        <div id="clockOutContent">
            <h2>Clock Out!</h2>
            <p>Take a moment to reset your focus. Your module will resume in:</p>
            <div id="brainEmoji">🧠</div> <div id="countdownTimer">00:30</div>
        </div>
    </div>
    <script>
        // ==========================================
        // Drug Data (This is the only part that can safely sit outside DOMContentLoaded)
        // ==========================================
        const drugs = [
            {
                name: "Metoprolol",
                class: "Selective Beta1 Blocker (Antihypertensive)",
                keyActions: "Blocks beta1 receptors to reduce heart rate, myocardial contractility, and blood pressure. Used for hypertension, acute MI, angina, and heart failure.",
                sideEffects: "Fatigue, dizziness, dry mouth, nausea, vomiting, diarrhea, insomnia, nightmares, drowsiness, headache, blurred vision, rash, pruritus, peripheral edema, tinnitus, erectile dysfunction, depression, bradycardia, hypotension, palpitations.",
                nursingConsiderations: "Do NOT abruptly discontinue (risk of rebound hypertension, angina, dysrhythmias, MI). Monitor HR and BP closely. Use cautiously in diabetes (can mask hypoglycemia or worsen glucose control) and COPD (less bronchospasm than non-selective, but still a risk). Less effective alone in African Americans; often combined with a diuretic."
            },
            {
                name: "Hydrochlorothiazide (HCTZ)",
                class: "Thiazide Diuretic (Antihypertensive)",
                keyActions: "Acts on distal convoluted renal tubule to promote sodium, chloride, and water excretion, decreasing fluid volume and peripheral resistance. Used for mild hypertension and peripheral edema.",
                sideEffects: "Hypokalemia, hypomagnesemia, hypercalcemia, hyperglycemia, hyperuricemia, hyperlipidemia, dizziness, headache, photosensitivity, orthostatic hypotension, GI upset.",
                nursingConsiderations: "Often first-line for mild hypertension. Administer in the morning. Monitor electrolytes (K+, Ca2+, Mg2+), glucose, uric acid, and lipids. Advise K+-rich foods/supplements if K+-wasting is significant. Teach slow position changes and sun protection. Less effective with severe renal dysfunction. Can increase digitalis toxicity if hypokalemia is present."
            },
            {
                name: "Clonidine",
                class: "Centrally Acting Alpha2 Agonist (Antihypertensive)",
                keyActions: "Stimulates alpha2 receptors in the brainstem, decreasing sympathetic outflow, leading to decreased heart rate, cardiac output, and peripheral vascular resistance. Used for hypertension.",
                sideEffects: "Drowsiness, dry mouth, dizziness, bradycardia, sodium and water retention (edema), fatigue, headache, constipation, impotence, rebound hypertension if abruptly discontinued.",
                nursingConsiderations: "Do NOT abruptly discontinue (risk of severe rebound hypertensive crisis). Monitor BP and HR. Often given with a diuretic to counteract fluid retention. Available in a 7-day transdermal patch (rotate sites, can cause skin irritation)."
            },
            {
                name: "Prazosin",
                class: "Selective Alpha1-Adrenergic Blocker (Antihypertensive)",
                keyActions: "Blocks alpha1-adrenergic receptors, causing vasodilation of arterioles and venules, decreasing peripheral resistance and lowering BP. Also used for benign prostatic hypertrophy (BPH). Improves lipid profiles (decreases VLDL/LDL, increases HDL).",
                sideEffects: "Orthostatic hypotension (especially first dose), dizziness, faintness, lightheadedness, headache, drowsiness, nasal congestion, edema, weight gain, nausea, impotence.",
                nursingConsiderations: "Teach 'first-dose effect' (syncope, dizziness with first dose); advise taking initial dose at bedtime. Teach slow position changes. Monitor for fluid retention/edema; often co-administered with a diuretic. Beneficial for patients with lipid abnormalities or diabetes (does not affect glucose metabolism). Highly protein bound."
            },
            {
                name: "Hydralazine",
                class: "Direct-Acting Arteriolar Vasodilator (Antihypertensive)",
                keyActions: "Relaxes smooth muscles of arteries, causing vasodilation, which decreases BP and increases blood flow to the brain and kidneys. Used for moderate to severe hypertension, hypertensive urgency/emergency, preeclampsia/eclampsia.",
                sideEffects: "Reflex tachycardia, palpitations, edema (sodium/water retention), nasal congestion, headache, dizziness, lupus-like syndrome (rare with high doses/long-term use), neurologic symptoms (tingling, numbness).",
                nursingConsiderations: "Often combined with a beta blocker to counteract reflex tachycardia and a diuretic to manage fluid retention. Monitor vital signs closely. Can cause reflex tachycardia."
            },
            {
                name: "Captopril",
                class: "Angiotensin-Converting Enzyme (ACE) Inhibitor (Antihypertensive)",
                keyActions: "Inhibits ACE, preventing formation of Angiotensin II and blocking aldosterone release. Results in vasodilation, sodium/water excretion, and potassium retention. Used for hypertension, heart failure, post-MI, diabetic nephropathy.",
                sideEffects: "Constant, irritating, nonproductive cough (common), nausea, vomiting, diarrhea, headache, dizziness, fatigue, insomnia, hyperkalemia, first-dose hypotension, angioedema (rare, serious, higher in African Americans), dysgeusia.",
                nursingConsiderations: "Do NOT use during pregnancy (fetotoxic). Do NOT use with potassium-sparing diuretics or potassium salt substitutes (risk of hyperkalemia). Monitor BP closely, especially first dose. Monitor renal function and potassium levels. Teach patient to report cough, swelling (angioedema), or taste changes. Take 20-60 minutes before meals for better absorption (unique for captopril)."
            },
            {
                name: "Valsartan",
                class: "Angiotensin II–Receptor Blocker (ARB) (Antihypertensive)",
                keyActions: "Blocks Angiotensin II from binding to AT1 receptors, causing potent vasodilation and decreased peripheral resistance. Prevents aldosterone release. Used for hypertension and heart failure.",
                sideEffects: "Dizziness, drowsiness, headache, edema, nausea, diarrhea, abdominal pain, fatigue, cough (less common than ACEIs), hyperkalemia, orthostatic hypotension, angioedema (rare).",
                nursingConsiderations: "Do NOT use during pregnancy (fetotoxic). Monitor renal function and potassium levels. Does not cause the ACEI cough. Less effective alone in African Americans. Can be taken with or without food. Monitor for fluid and electrolyte imbalances."
            },
            {
                name: "Amlodipine",
                class: "Dihydropyridine Calcium Channel Blocker (Antihypertensive)",
                keyActions: "Inhibits influx of extracellular calcium across myocardial and vascular smooth muscle cell membranes, promoting vasodilation (mainly peripheral arterioles) and decreasing myocardial contractility. Used for hypertension and coronary artery disease (e.g., angina).",
                sideEffects: "Flushing, headache, dizziness, ankle edema (peripheral edema), fatigue, weakness, syncope, nausea, abdominal pain, palpitations, orthostatic hypotension, bradycardia (less common than non-dihydropyridine CCBs).",
                nursingConsiderations: "Administer once daily. Monitor BP and HR. Peripheral edema is a common side effect. Generally effective in African Americans. Avoid immediate-release nifedipine due to safety concerns (use extended release for chronic HTN). Can be combined with ACE inhibitors."
            },
            {
                name: "Aliskiren",
                class: "Direct Renin Inhibitor (Antihypertensive)",
                keyActions: "Directly binds with renin, reducing levels of angiotensin I, angiotensin II, and aldosterone. This leads to vasodilation and decreased BP. Used for mild to moderate hypertension.",
                sideEffects: "Dizziness, hypotension, hyperkalemia, peripheral edema, diarrhea, hyperuricemia, gout, pharyngitis, cough.",
                nursingConsiderations: "Do NOT use during pregnancy. Monitor renal function and potassium levels (risk of hyperkalemia, especially if combined with ACEIs or ARBs). Less effective as monotherapy in African Americans."
            }
        ];

        // ==========================================
        // ALL JavaScript code and functions MUST be inside this single DOMContentLoaded listener.
        // This ensures all HTML elements are available when the script tries to access them.
        // ==========================================
        document.addEventListener('DOMContentLoaded', () => {

            // --- QUIZ VARIABLES AND ELEMENT SELECTIONS ---
            let currentQuizDrugsCopy = [];
            let currentDrugIndex = 0;
            let masteredDrugs = [];
            let missedDrugs = [];
            const questionTypes = ['class', 'keyActions', 'sideEffects', 'nursingConsiderations'];

            const startQuizBtn = document.getElementById('startQuizBtn');
            const drugQuizCard = document.getElementById('drugQuizCard');
            const drugNameEl = document.getElementById('drugName');
            const drugQuestionEl = document.getElementById('drugQuestion');
            const showAnswerBtn = document.getElementById('showAnswerBtn');
            const answerFeedbackEl = document.getElementById('answerFeedback');
            const answerTypeEl = document.getElementById('answerType');
            const answerContentEl = document.getElementById('answerContent');
            const masteryButtons = document.getElementById('masteryButtons');
            const correctBtn = document.getElementById('correctBtn');
            const incorrectBtn = document.getElementById('incorrectBtn');
            const quizSummary = document.getElementById('quizSummary');
            const masteredCountEl = document.getElementById('masteredCount');
            const missedCountEl = document.getElementById('missedCount');
            const restartQuizBtn = document.getElementById('restartQuizBtn');
            const reviewMissedBtn = document.getElementById('reviewMissedBtn');
            const currentCardNumEl = document.getElementById('currentCardNum');
            const totalCardsNumEl = document.getElementById('totalCardsNum');

            // --- MODULE PROGRESS BAR VARIABLES ---
            const moduleProgressBar = document.getElementById('moduleProgressBar');
            const sections = document.querySelectorAll('section[id]'); // Select all sections with an ID
            let completedSectionsCount = 0; // Tracks number of completed logical sections

            const completableSectionIds = new Set();
            // Populate completableSectionIds with all relevant section IDs
            document.querySelectorAll('section').forEach(section => {
                // Consider a section completable if it has a reveal button, a question card, or a text area (for case study)
                // and it's not the overall intro or objectives (which are auto-completed or just setup)
                // The quiz section itself should also count.
                if (section.id && (section.querySelector('.reveal-button') || section.querySelector('.question-card') || section.id === 'drug-mastery-quiz' || section.id === 'critical-thinking' || section.querySelector('textarea'))) {
                    completableSectionIds.add(section.id);
                }
            });

            // This line MUST be after completableSectionIds is fully populated
            const totalSections = completableSectionIds.size;


            // --- HELPER FUNCTIONS ---

            function updateProgressBar() {
                const progress = (completedSectionsCount / totalSections) * 100;
                moduleProgressBar.style.width = `${progress}%`;
            }

            function markSectionCompleted(sectionId) {
                const navLink = document.getElementById('nav-' + sectionId); // Use ID now
                if (navLink && !navLink.classList.contains('completed')) {
                    navLink.classList.add('completed');
                    if (completableSectionIds.has(sectionId)) {
                        completedSectionsCount++;
                        updateProgressBar();
                        // Trigger micro-break only if the "clock out" overlay is not active
                        if (!document.getElementById('clockOutOverlay').classList.contains('active')) {
                            // Changed to trigger every 3 sections (after the 3rd, 6th, 9th, etc.)
                            if (completedSectionsCount > 0 && completedSectionsCount % 3 === 0 && completedSectionsCount !== totalSections) {
                                showMicroBreakPrompt();
                            }
                        }
                    }
                }
            }

            // --- Manual scrolling for navigation links ---
            document.querySelectorAll('nav ul li a').forEach(link => {
                link.addEventListener('click', function(event) {
                    event.preventDefault(); // Prevent default link behavior (no page reload/new tab)
                    const targetId = this.id.replace('nav-', ''); // Get the actual section ID
                    const targetSection = document.getElementById(targetId);
                    if (targetSection) {
                        targetSection.scrollIntoView({ behavior: 'smooth', block: 'start' });
                        // Optionally, update the URL hash without reloading
                        // window.location.hash = targetId;
                    }
                });
            });

            // toggleReveal function (now called by event listener, no longer onclick)
            function toggleReveal(button) {
                const content = button.nextElementSibling;
                if (content.style.display === "block") {
                    content.style.display = "none";
                    button.textContent = button.dataset.originalText;
                } else {
                    content.style.display = "block";
                    button.dataset.originalText = button.textContent;
                    button.textContent = "Click to Hide Details";
                    const parentSection = button.closest('section');
                    if (parentSection && parentSection.id) {
                        markSectionCompleted(parentSection.id);
                    }
                }
            }

            // --- Question Checking Functions ---
            function checkAnswer(questionId, correctAnswer) {
                const questionCard = document.getElementById(questionId);
                const selectedOption = questionCard.querySelector('input[name="' + questionId + '_option"]:checked');
                const feedbackDiv = questionCard.querySelector('.feedback');

                // Disable options after submission
                questionCard.querySelectorAll('input[type="radio"]').forEach(input => input.disabled = true);
                const submitBtn = questionCard.querySelector('.submit-btn');
                if (submitBtn) {
                    submitBtn.disabled = true;
                }

                if (!selectedOption) {
                    feedbackDiv.textContent = "Oops! Please pick an answer before checking.";
                    feedbackDiv.className = 'feedback incorrect';
                    feedbackDiv.style.display = 'block';
                    return;
                }

                if (selectedOption.value === correctAnswer) {
                    feedbackDiv.textContent = "Awesome! That's correct. Keep up the great work!";
                    feedbackDiv.className = 'feedback correct';
                } else {
                    feedbackDiv.textContent = `Not quite! The correct answer was: ${correctAnswer.toUpperCase()}. Review the material and try to understand why.`;
                    feedbackDiv.className = 'feedback incorrect';
                }
                feedbackDiv.style.display = 'block';
                markSectionCompleted(questionCard.closest('section').id);
            }

            function checkMultipleAnswers(questionId, correctAnswers) {
                const questionCard = document.getElementById(questionId);
                const selectedOptions = Array.from(questionCard.querySelectorAll('input[name="' + questionId + '_option"]:checked')).map(input => input.value);
                const feedbackDiv = questionCard.querySelector('.feedback');

                // Disable options after submission
                questionCard.querySelectorAll('input[type="checkbox"]').forEach(input => input.disabled = true);
                const submitBtn = questionCard.querySelector('.submit-btn');
                if (submitBtn) {
                    submitBtn.disabled = true;
                }


                if (selectedOptions.length === 0) {
                    feedbackDiv.textContent = "Don't forget to select your answers!";
                    feedbackDiv.className = 'feedback incorrect';
                    feedbackDiv.style.display = 'block';
                    return;
                }

                // Convert correctAnswers to a Set for efficient lookup
                const correctSet = new Set(correctAnswers);

                // Check if all selected options are in the correct answers AND
                // if all correct answers were selected (no missing ones)
                const isCorrect = selectedOptions.every(answer => correctSet.has(answer)) &&
                                correctAnswers.every(answer => selectedOptions.includes(answer)) &&
                                selectedOptions.length === correctAnswers.length; // Ensure no extra incorrect options were selected

                if (isCorrect) {
                    feedbackDiv.textContent = "Fantastic! You got all the correct points!";
                    feedbackDiv.className = 'feedback correct';
                } else {
                    feedbackDiv.textContent = `Hold on! Double-check the options and review the related content. You might have missed something or picked too many/too few. Correct answers were: ${correctAnswers.map(ans => ans.toUpperCase()).join(', ')}.`;
                    feedbackDiv.className = 'feedback incorrect';
                }
                feedbackDiv.style.display = 'block';
                markSectionCompleted(questionCard.closest('section').id);
            }

            function checkCaseStudy() {
                const feedbackDiv = document.getElementById('case_study_feedback');
                const rationaleDiv = document.getElementById('case_study_rationale');

                // Disable inputs and button after submission
                document.querySelectorAll('#critical-thinking textarea, #critical-thinking input').forEach(input => input.disabled = true);
                document.getElementById('submit_case_study').disabled = true;

                // For the case study, we just enable the rationale. It's a free-text input type question.
                feedbackDiv.textContent = "Review the rationale below to check your answers and deepen your understanding!";
                feedbackDiv.className = 'feedback info'; // Neutral feedback
                feedbackDiv.style.display = 'block';
                rationaleDiv.style.display = 'block';
                markSectionCompleted('critical-thinking');
            }


            // --- DRUG MASTERY QUIZ FUNCTIONS ---
            function shuffleArray(array) {
                for (let i = array.length - 1; i > 0; i--) {
                    const j = Math.floor(Math.random() * (i + 1));
                    [array[i], array[j]] = [array[j], array[i]];
                }
                return array;
            }

            function startQuiz(reviewMode = false) {
                if (!reviewMode) {
                    currentQuizDrugsCopy = shuffleArray([...drugs]); // Start with all drugs shuffled
                    masteredDrugs = [];
                    missedDrugs = [];
                } else {
                    // This block handles the case where the user wants to review missed drugs
                    // It also handles if there are no missed drugs left to review
                    if (missedDrugs.length === 0) {
                        // Display message to user about no more missed drugs, then restart full quiz
                        quizSummary.querySelector('h4').textContent = "Great job! No missed drugs left!";
                        quizSummary.querySelector('p:first-of-type').textContent = "You've successfully reviewed all the drugs you previously needed to review. Starting a new full quiz.";
                        quizSummary.style.display = 'block'; // Ensure summary is visible to show message
                        drugQuizCard.style.display = 'none'; // Hide quiz card
                        startQuizBtn.style.display = 'block'; // Show start button again
                        return; // Exit function, don't start new round immediately without user interaction
                    } else {
                        currentQuizDrugsCopy = shuffleArray([...missedDrugs]); // Only review missed ones
                        missedDrugs = []; // Clear missed for the new review round
                    }
                }

                currentDrugIndex = 0;
                startQuizBtn.style.display = 'none';
                drugQuizCard.style.display = 'block';
                quizSummary.style.display = 'none';
                displayCurrentCard();
                markSectionCompleted('drug-mastery-quiz'); // Mark quiz section completed when started
            }

            function displayCurrentCard() {
                if (currentDrugIndex >= currentQuizDrugsCopy.length) {
                    showQuizSummary();
                    return;
                }

                const currentDrug = currentQuizDrugsCopy[currentDrugIndex];
                const randomQuestionType = questionTypes[Math.floor(Math.random() * questionTypes.length)];

                drugNameEl.textContent = currentDrug.name;
                currentCardNumEl.textContent = currentDrugIndex + 1;
                totalCardsNumEl.textContent = currentQuizDrugsCopy.length;

                let questionText = '';
                switch (randomQuestionType) {
                    case 'class':
                        questionText = `What is the **drug class** for ${currentDrug.name}?`;
                        break;
                    case 'keyActions':
                        questionText = `What is a **key action or use** of ${currentDrug.name}?`;
                        break;
                    case 'sideEffects':
                        questionText = `Name one or two **common side effects** of ${currentDrug.name}.`;
                        break;
                    case 'nursingConsiderations':
                        questionText = `What is an **important nursing consideration** when administering ${currentDrug.name}?`;
                        break;
                }
                drugQuestionEl.innerHTML = questionText;

                answerFeedbackEl.style.display = 'none';
                masteryButtons.style.display = 'none';
                showAnswerBtn.style.display = 'block';

                drugQuizCard.dataset.currentQuestionType = randomQuestionType;
            }

            function showAnswer() {
                const currentDrug = currentQuizDrugsCopy[currentDrugIndex];
                const questionType = drugQuizCard.dataset.currentQuestionType;

                answerTypeEl.textContent = questionType.replace(/([A-Z])/g, ' $1').toLowerCase().replace(/^./, str => str.toUpperCase());

                let content = '';
                switch (questionType) {
                    case 'class':
                        content = currentDrug.class;
                        break;
                    case 'keyActions':
                        content = currentDrug.keyActions;
                        break;
                    case 'sideEffects':
                        content = currentDrug.sideEffects;
                        break;
                    case 'nursingConsiderations':
                        content = currentDrug.nursingConsiderations;
                        break;
                }
                answerContentEl.textContent = content;

                answerFeedbackEl.style.display = 'block';
                showAnswerBtn.style.display = 'none';
                masteryButtons.style.display = 'flex';
            }

            function handleMastery(isCorrect) {
                const currentDrug = currentQuizDrugsCopy[currentDrugIndex];
                if (isCorrect) {
                    // Only add to mastered if it wasn't previously in missed (first attempt correct)
                    // If it was in missed and now correct, it still 'counts' as correct this round
                    if (!missedDrugs.includes(currentDrug)) {
                        masteredDrugs.push(currentDrug);
                    }
                } else {
                    missedDrugs.push(currentDrug);
                }
                masteryButtons.style.display = 'none';

                setTimeout(() => {
                    currentDrugIndex++;
                    displayCurrentCard();
                }, 1500); // 1.5 second delay before next card
            }

            function showQuizSummary() {
                drugQuizCard.style.display = 'none';
                quizSummary.style.display = 'block';

                const uniqueMastered = [...new Set(masteredDrugs)];
                const uniqueMissed = [...new Set(missedDrugs)];

                masteredCountEl.textContent = uniqueMastered.length;
                missedCountEl.textContent = uniqueMissed.length;

                // Customize summary message
                if (uniqueMissed.length === 0 && uniqueMastered.length === drugs.length) {
                    quizSummary.querySelector('h4').textContent = "Congratulations! All Drugs Mastered!";
                    quizSummary.querySelector('p:first-of-type').textContent = "You knew every drug on your first try or successfully reviewed all of them!";
                } else if (uniqueMastered.length > 0 && uniqueMissed.length > 0) {
                    quizSummary.querySelector('h4').textContent = "Challenge Complete!";
                    quizSummary.querySelector('p:first-of-type').textContent = "You've gone through all the drugs. Keep reviewing the ones you missed!";
                } else {
                    quizSummary.querySelector('h4').textContent = "Good effort!";
                    quizSummary.querySelector('p:first-of-type').textContent = "Review the concepts and try again to master all the drugs.";
                }
            }

            // --- EVENT LISTENERS ---

            // Attach event listeners for all reveal buttons
            document.querySelectorAll('.reveal-button').forEach(button => {
                button.addEventListener('click', function() {
                    toggleReveal(this); // 'this' refers to the button that was clicked
                });
            });

            // Attach event listeners for quiz question submit buttons (by their IDs)
            document.getElementById('submit_q1').addEventListener('click', () => checkMultipleAnswers('q1', ['a', 'b', 'c', 'd']));
            document.getElementById('submit_q2').addEventListener('click', () => checkAnswer('q2', 'a'));
            document.getElementById('submit_q3').addEventListener('click', () => checkAnswer('q3', 'c'));
            document.getElementById('submit_q4').addEventListener('click', () => checkAnswer('q4', 'b'));
            document.getElementById('submit_q5').addEventListener('click', () => checkAnswer('q5', 'b'));
            document.getElementById('submit_q6').addEventListener('click', () => checkAnswer('q6', 'd'));
            document.getElementById('submit_q7').addEventListener('click', () => checkAnswer('q7', 'b'));
            document.getElementById('submit_q8').addEventListener('click', () => checkMultipleAnswers('q8', ['b', 'c', 'e']));

            document.getElementById('submit_case_study').addEventListener('click', checkCaseStudy);


            // Quiz Mastery Challenge Event Listeners
            startQuizBtn.addEventListener('click', () => startQuiz(false));
            showAnswerBtn.addEventListener('click', showAnswer);
            correctBtn.addEventListener('click', () => handleMastery(true));
            incorrectBtn.addEventListener('click', () => handleMastery(false));
            restartQuizBtn.addEventListener('click', () => startQuiz(false));
            reviewMissedBtn.addEventListener('click', () => startQuiz(true));

            // Text Size Controls
            const increaseTextBtn = document.getElementById('increaseText');
            const decreaseTextBtn = document.getElementById('decreaseText');
            let currentFontSize = 16; // Base font size in px (matches default Open Sans)

            increaseTextBtn.addEventListener('click', () => {
                currentFontSize += 2;
                document.body.style.fontSize = `${currentFontSize}px`;
            });

            decreaseTextBtn.addEventListener('click', () => {
                currentFontSize -= 2;
                if (currentFontSize < 12) currentFontSize = 12; // Minimum size
                document.body.style.fontSize = `${currentFontSize}px`;
            });

            // Quick Notes persistence (uses localStorage)
            const quickNotesTextarea = document.getElementById('quickNotesTextarea');
            if (localStorage.getItem('antihypertensivesModuleNotes')) {
                quickNotesTextarea.value = localStorage.getItem('antihypertensivesModuleNotes');
            }
            quickNotesTextarea.addEventListener('input', () => {
                localStorage.setItem('antihypertensivesModuleNotes', quickNotesTextarea.value);
            });

            // Micro-Break Prompts (Original functionality without Clock Out)
            const microBreakPromptEl = document.getElementById('microBreakPrompt');
            const breakPrompts = [
                "Quick Break! Stand up and stretch, or take a few deep breaths!",
                "Time for a 30-second mental reset. Look away from the screen for a moment!",
                "Mini-Break! Wiggle your toes or do a quick shoulder roll.",
                "Focus check! Take a sip of water and recenter. You're doing great!",
                "Short pause! How about a quick doodle or scribble for 15 seconds!"
            ];
            let breakPromptTimeout;

            function showMicroBreakPrompt() {
                if (breakPromptTimeout) {
                    clearTimeout(breakPromptTimeout);
                }
                const randomPrompt = breakPrompts[Math.floor(Math.random() * breakPrompts.length)];
                microBreakPromptEl.textContent = randomPrompt;
                microBreakPromptEl.style.display = 'block';
                // Set a timer to hide it after the animation
                breakPromptTimeout = setTimeout(() => {
                    microBreakPromptEl.style.display = 'none';
                }, 8000); // Matches animation duration
            }

            // --- Initial setup calls that run once DOM is fully loaded ---
            // Initialize reveal button original text (needed for toggleReveal)
            document.querySelectorAll('.reveal-button').forEach(button => {
                button.dataset.originalText = button.textContent;
            });
            updateProgressBar(); // Initial update
        }); // END OF document.addEventListener('DOMContentLoaded', ...)
    </script>
</body>
</html>
